CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: beta-lactam antibiotic
Accession: CHEBI:27933
browse the term
Definition: An organonitrogen heterocyclic antibiotic that contains a beta-lactam ring.
Synonyms: related_synonym: beta-Lactam antibiotics
alt_id: CHEBI:10427; CHEBI:22844
xref: KEGG:C03438; PMID:19254642; PMID:22594007; Wikipedia:Beta-lactam_antibiotic
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of AMPD3 mRNA
CTD
PMID:24211530
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Fth1
ferritin heavy chain 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of FTH1 mRNA
CTD
PMID:24211530
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Ftl1
ferritin light chain 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of FTL mRNA
CTD
PMID:24211530
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of GCLM mRNA
CTD
PMID:24211530
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Hmox1
heme oxygenase 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of HMOX1 mRNA
CTD
PMID:24211530
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of MYC mRNA
CTD
PMID:24211530
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of NQO1 mRNA
CTD
PMID:24211530
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Sel1l3
SEL1L family member 3
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of SEL1L3 mRNA
CTD
PMID:24211530
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of SLC7A11 mRNA
CTD
PMID:24211530
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Sqstm1
sequestosome 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of SQSTM1 mRNA
CTD
PMID:24211530
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA
CTD
PMID:24211530
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Tnnt2
troponin T2, cardiac type
decreases expression
ISO
7-aminocephalosporanic acid results in decreased expression of TNNT2 mRNA
CTD
PMID:24211530
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
7-aminocephalosporanic acid results in increased expression of TXNRD1 mRNA
CTD
PMID:24211530
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Amoxicillin results in increased expression of AKR1B10 mRNA
CTD
PMID:28444390
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
Amoxicillin results in decreased phosphorylation of AKT1 protein
CTD
PMID:36529298
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Amh
anti-Mullerian hormone
increases expression
ISO
Amoxicillin results in increased expression of AMH mRNA
CTD
PMID:36529298
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
G
Aqp5
aquaporin 5
decreases expression
EXP
Amoxicillin results in decreased expression of AQP5 protein
CTD
PMID:30031112
NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
G
Casp3
caspase 3
increases expression
ISO
Amoxicillin results in increased expression of CASP3 mRNA; Amoxicillin results in increased expression of CASP3 protein
CTD
PMID:36529298
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
decreases activity
EXP
Amoxicillin results in decreased activity of CAT protein
CTD
PMID:26429924
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cxcl10
C-X-C motif chemokine ligand 10
decreases expression
ISO
Amoxicillin results in decreased expression of CXCL10 mRNA
CTD
PMID:25091725
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
decreases expression
ISO
Amoxicillin results in decreased expression of CYP11A1 mRNA
CTD
PMID:36529298
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
increases expression
ISO
Amoxicillin results in increased expression of CYP11B2
CTD
PMID:17822730
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
ISO
Amoxicillin results in decreased expression of CYP17A1 mRNA
CTD
PMID:36529298
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
ISO
Amoxicillin results in increased expression of CYP19A1
CTD
PMID:17822730
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
multiple interactions decreases activity
ISO
Amoxicillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] Amoxicillin results in decreased activity of CYP2C8 protein
CTD
PMID:26763401
G
Gfra1
GDNF family receptor alpha 1
decreases expression
ISO
Amoxicillin results in decreased expression of GFRA1 mRNA
CTD
PMID:36529298
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Gsr
glutathione-disulfide reductase
decreases activity
ISO
Amoxicillin results in decreased activity of GSR protein
CTD
PMID:32196862
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
Amoxicillin results in decreased phosphorylation of MAPK1 protein
CTD
PMID:36529298
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
Amoxicillin results in decreased phosphorylation of MAPK3 protein
CTD
PMID:36529298
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
Amoxicillin results in decreased expression of MKI67 mRNA; Amoxicillin results in decreased expression of MKI67 protein
CTD
PMID:36529298
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Amoxicillin results in increased expression of NQO1 mRNA
CTD
PMID:28444390
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr5a1
nuclear receptor subfamily 5, group A, member 1
decreases expression
ISO
Amoxicillin results in decreased expression of NR5A1 mRNA
CTD
PMID:36529298
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
Amoxicillin results in decreased expression of PCNA mRNA; Amoxicillin results in decreased expression of PCNA protein
CTD
PMID:36529298
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
RT1-Bb
RT1 class II, locus Bb
affects expression
ISO
Amoxicillin affects the expression of HLA-DQB1 mRNA
CTD
PMID:25811541
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Slc51a
solute carrier family 51 member A
increases expression
ISO
Amoxicillin results in increased expression of SLC51A mRNA
CTD
PMID:34767876
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Amoxicillin results in increased expression of SRXN1 mRNA
CTD
PMID:28444390
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Star
steroidogenic acute regulatory protein
decreases expression
ISO
Amoxicillin results in decreased expression of STAR mRNA; Amoxicillin results in decreased expression of STAR protein
CTD
PMID:36529298
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Zbtb16
zinc finger and BTB domain containing 16
decreases expression
ISO
Amoxicillin results in decreased expression of ZBTB16 mRNA; Amoxicillin results in decreased expression of ZBTB16 protein
CTD
PMID:36529298
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCA1 mRNA
CTD
PMID:36464106
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB11 mRNA
CTD
PMID:36464106
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB1A mRNA
CTD
PMID:36464106
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA
CTD
PMID:36464106
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
decreases expression multiple interactions
ISO
Ampicillin results in decreased expression of ABCC3 mRNA [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC3 mRNA
CTD
PMID:21632981 PMID:36464106
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Ampicillin
CTD
PMID:17939016
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA
CTD
PMID:36464106
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abcg5
ATP binding cassette subfamily G member 5
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA
CTD
PMID:36464106
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2 protein
CTD
PMID:30545405
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Acat2l1
acetyl-CoA acetyltransferase 2-like 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2L1 protein
CTD
PMID:30545405
NCBI chr 1:47,803,822...47,829,012
Ensembl chr 1:47,803,813...47,829,151
G
Ace2
angiotensin converting enzyme 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACE2 protein
CTD
PMID:30545405
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Ager
advanced glycosylation end product-specific receptor
decreases expression
ISO
Ampicillin results in decreased expression of AGER mRNA
CTD
PMID:24747151
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Ahsg
alpha-2-HS-glycoprotein
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of AHSG protein
CTD
PMID:30545405
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
G
Akr1b10
aldo-keto reductase family 1 member B10
decreases expression
ISO
Ampicillin results in decreased expression of AKR1B10 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c2
aldo-keto reductase family 1, member C2
decreases expression
ISO
Ampicillin results in decreased expression of AKR1C2 mRNA
CTD
PMID:21632981
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Aldoa
aldolase, fructose-bisphosphate A
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein
CTD
PMID:30545405
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldob
aldolase, fructose-bisphosphate B
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOB protein
CTD
PMID:30545405
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Amot
angiomotin
increases expression
ISO
Ampicillin results in increased expression of AMOT mRNA
CTD
PMID:21632981
NCBI chr X:108,982,399...109,041,265
Ensembl chr X:108,984,022...109,041,272
G
Ankrd1
ankyrin repeat domain 1
increases expression
ISO
Ampicillin results in increased expression of ANKRD1 mRNA
CTD
PMID:21632981
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Aqp3
aquaporin 3 (Gill blood group)
decreases expression
ISO
Ampicillin results in decreased expression of AQP3 mRNA
CTD
PMID:21632981
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Arg1
arginase 1
increases expression
ISO
Ampicillin results in increased expression of ARG1 mRNA
CTD
PMID:21632981
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Arg2
arginase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ARG2 protein
CTD
PMID:30545405
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgdia
Rho GDP dissociation inhibitor alpha
increases expression
ISO
Ampicillin results in increased expression of ARHGDIA mRNA
CTD
PMID:21632981
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Arpc3
actin related protein 2/3 complex, subunit 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ARPC3 protein
CTD
PMID:30545405
NCBI chr12:34,172,780...34,186,651
Ensembl chr12:34,172,780...34,186,651
G
Arrdc3
arrestin domain containing 3
decreases expression
ISO
Ampicillin results in decreased expression of ARRDC3 mRNA
CTD
PMID:21632981
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Arrdc4
arrestin domain containing 4
decreases expression
ISO
Ampicillin results in decreased expression of ARRDC4 mRNA
CTD
PMID:21632981
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
G
Asah1
N-acylsphingosine amidohydrolase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ASAH1 protein
CTD
PMID:30545405
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
Ampicillin results in decreased expression of ASNS mRNA
CTD
PMID:21632981
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP1A1 protein
CTD
PMID:30545405
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP2A3 protein
CTD
PMID:30545405
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
G
Atp5mf
ATP synthase membrane subunit f
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein
CTD
PMID:30545405
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
G
Atp5pd
ATP synthase peripheral stalk subunit d
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PD protein
CTD
PMID:30545405
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
G
Atp5pf
ATP synthase peripheral stalk subunit F6
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PF protein
CTD
PMID:30545405
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
G
B3galt5
Beta-1,3-galactosyltransferase 5
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of B3GALT5 protein
CTD
PMID:30545405
NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917
G
Bax
BCL2 associated X, apoptosis regulator
increases response to substance
ISO
BAX results in increased susceptibility to Ampicillin
CTD
PMID:15731293
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bpifb2
BPI fold containing family B, member 2
increases expression
ISO
Ampicillin results in increased expression of BPIFB2 mRNA
CTD
PMID:21632981
NCBI chr 3:142,356,990...142,377,053
Ensembl chr 3:142,358,051...142,377,044
G
Calr
calreticulin
increases expression
ISO
Ampicillin results in increased expression of CALR mRNA
CTD
PMID:21632981
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Car9
carbonic anhydrase 9
increases expression
ISO
Ampicillin results in increased expression of CA9 mRNA
CTD
PMID:21632981
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
G
Ccn1
cellular communication network factor 1
increases expression
ISO
Ampicillin results in increased expression of CCN1 mRNA
CTD
PMID:21632981
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccpg1
cell cycle progression 1
decreases expression
ISO
Ampicillin results in decreased expression of CCPG1 mRNA
CTD
PMID:21632981
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
G
Cd40
CD40 molecule
increases expression
ISO
Ampicillin results in increased expression of CD40 mRNA
CTD
PMID:25091725
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Ces1d
carboxylesterase 1D
increases expression
ISO
Ampicillin results in increased expression of CES1 mRNA
CTD
PMID:22609641
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Chst15
carbohydrate sulfotransferase 15
increases expression
ISO
Ampicillin results in increased expression of CHST15 mRNA
CTD
PMID:21632981
NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707
G
Ckb
creatine kinase B
increases expression
ISO
Ampicillin results in increased expression of CKB mRNA
CTD
PMID:21632981
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
G
Clca4
chloride channel accessory 4
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein
CTD
PMID:30545405
NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:233,883,851...233,903,089
G
Cldn5
claudin 5
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein]
CTD
PMID:35390362
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Cldn7
claudin 7
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLDN7 protein
CTD
PMID:30545405
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
G
Clgn
calmegin
decreases expression
ISO
Ampicillin results in decreased expression of CLGN mRNA
CTD
PMID:21632981
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
G
Clic3
chloride intracellular channel 3
increases expression
ISO
Ampicillin results in increased expression of CLIC3 mRNA
CTD
PMID:21632981
NCBI chr 3:8,271,416...8,274,023
Ensembl chr 3:8,272,097...8,274,018
G
Cmbl
carboxymethylenebutenolidase homolog
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CMBL protein
CTD
PMID:30545405
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cndp2
carnosine dipeptidase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein
CTD
PMID:30545405
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
G
Cox5a
cytochrome c oxidase subunit 5A
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX5A protein
CTD
PMID:30545405
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
G
Cox6b1
cytochrome c oxidase subunit 6B1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6B1 protein
CTD
PMID:30545405
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001
G
Cox7a2
cytochrome c oxidase subunit 7A2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX7A2 protein
CTD
PMID:30545405
NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633 Ensembl chr 8:51,301,168...51,301,633
G
Cp
ceruloplasmin
increases expression
ISO
Ampicillin results in increased expression of CP mRNA
CTD
PMID:21632981
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Creb3l3
cAMP responsive element binding protein 3-like 3
decreases expression
ISO
Ampicillin results in decreased expression of CREB3L3 mRNA
CTD
PMID:21632981
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of CSF2 protein
CTD
PMID:31442584
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csta
cystatin A
decreases expression
ISO
Ampicillin results in decreased expression of CSTA mRNA
CTD
PMID:21632981
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
G
Ctsa
cathepsin A
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CTSA protein
CTD
PMID:30545405
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
Ampicillin results in increased expression of CXCL2 mRNA
CTD
PMID:24747151
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
ISO
Ampicillin results in decreased expression of CYP1A1 mRNA
CTD
PMID:21632981
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA
CTD
PMID:30545405
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
decreases expression
ISO
Ampicillin results in decreased expression of CYP24A1 mRNA
CTD
PMID:21632981
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA
CTD
PMID:36464106
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA
CTD
PMID:30545405
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2d2
cytochrome P450, family 2, subfamily d, polypeptide 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2D2 mRNA
CTD
PMID:30545405
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2E1 mRNA
CTD
PMID:30545405
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP3A2 mRNA
CTD
PMID:30545405
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA
CTD
PMID:36464106
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7B1 mRNA
CTD
PMID:36464106
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA
CTD
PMID:36464106
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
increases expression
ISO
Ampicillin results in increased expression of DKK1 mRNA
CTD
PMID:21632981
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Ampicillin results in increased expression of DUSP1 mRNA
CTD
PMID:21632981
NCBI chr10:16,680,478...16,683,275
G
Dusp7
dual specificity phosphatase 7
increases expression
ISO
Ampicillin results in increased expression of DUSP7 mRNA
CTD
PMID:21632981
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
G
Edn1
endothelin 1
increases expression
ISO
Ampicillin results in increased expression of EDN1 mRNA
CTD
PMID:21632981
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Epcam
epithelial cell adhesion molecule
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EPCAM protein
CTD
PMID:30545405
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Esm1
endothelial cell-specific molecule 1
decreases expression
ISO
Ampicillin results in decreased expression of ESM1 mRNA
CTD
PMID:21632981
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Etfa
electron transfer flavoprotein subunit alpha
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ETFA protein
CTD
PMID:30545405
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
G
Ezr
ezrin
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EZR protein
CTD
PMID:30545405
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
Fasn
fatty acid synthase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA
CTD
PMID:36464106
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Filip1l
filamin A interacting protein 1-like
increases expression
ISO
Ampicillin results in increased expression of FILIP1L mRNA
CTD
PMID:21632981
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
G
Fxyd1
FXYD domain-containing ion transport regulator 1
increases expression
ISO
Ampicillin results in increased expression of FXYD1 mRNA
CTD
PMID:21632981
NCBI chr 1:86,287,163...86,291,478
Ensembl chr 1:86,287,165...86,291,278
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
ISO
Ampicillin results in decreased expression of GCLC mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
decreases expression increases expression
ISO
Ampicillin results in decreased expression of GCLM mRNA Ampicillin results in increased expression of GCLM mRNA
CTD
PMID:21632981 PMID:22609641
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein
CTD
PMID:30545405
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
G
Gipc2
GIPC PDZ domain containing family, member 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GIPC2 protein
CTD
PMID:30545405
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
G
Gng12
G protein subunit gamma 12
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GNG12 protein
CTD
PMID:30545405
NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
G
Gpat3
glycerol-3-phosphate acyltransferase 3
decreases expression
ISO
Ampicillin results in decreased expression of GPAT3 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein
CTD
PMID:36464106
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GPX1 protein
CTD
PMID:30545405
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gsta3
glutathione S-transferase alpha 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTA3 mRNA
CTD
PMID:30545405
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gstm2
glutathione S-transferase mu 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA
CTD
PMID:30545405
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Hexb
hexosaminidase subunit beta
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of HEXB protein
CTD
PMID:30545405
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
G
Hmgb1
high mobility group box 1
increases expression
ISO
Ampicillin results in increased expression of HMGB1 protein
CTD
PMID:24747151
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA
CTD
PMID:36464106
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
increases expression
ISO
Ampicillin results in increased expression of HMOX1 mRNA
CTD
PMID:25091725
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnph2
heterogeneous nuclear ribonucleoprotein H2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HNRNPH2 protein
CTD
PMID:30545405
NCBI chr X:97,780,890...97,786,846
Ensembl chr X:97,780,785...97,787,041
G
Hoxd1
homeo box D1
increases expression
ISO
Ampicillin results in increased expression of HOXD1 mRNA
CTD
PMID:21632981
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Hp
haptoglobin
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HP protein
CTD
PMID:30545405
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Ifrd1
interferon-related developmental regulator 1
decreases expression
ISO
Ampicillin results in decreased expression of IFRD1 mRNA
CTD
PMID:21632981
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Igfbp3
insulin-like growth factor binding protein 3
increases expression
ISO
Ampicillin results in increased expression of IGFBP3 mRNA
CTD
PMID:21632981
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Il18
interleukin 18
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased secretion of IL18 protein]
CTD
PMID:35390362
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
multiple interactions increases expression
EXP ISO
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]] [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of IL1B protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA] Ampicillin results in increased expression of IL1B mRNA
CTD
PMID:21893697 PMID:24747151 PMID:35390362
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein]
CTD
PMID:31442584
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jdp2
Jun dimerization protein 2
decreases expression
ISO
Ampicillin results in decreased expression of JDP2 mRNA
CTD
PMID:21632981
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Ampicillin results in increased expression of JUND mRNA
CTD
PMID:21632981
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kng2
kininogen 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAP1 protein
CTD
PMID:30545405
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
G
Krt16
keratin 16
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of KRT16 protein
CTD
PMID:30545405
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA
CTD
PMID:36464106
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lox
lysyl oxidase
increases expression
ISO
Ampicillin results in increased expression of LOX mRNA
CTD
PMID:21632981
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Lpin1
lipin 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA
CTD
PMID:36464106
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lyz2
lysozyme 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein
CTD
PMID:30545405
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAPK3 protein
CTD
PMID:30545405
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Maz
MYC associated zinc finger protein
increases expression
ISO
Ampicillin results in increased expression of MAZ mRNA
CTD
PMID:21632981
NCBI chr 1:181,629,742...181,635,193
Ensembl chr 1:181,629,729...181,650,408
G
Mpo
myeloperoxidase
multiple interactions
EXP
Ampicillin inhibits the reaction [Indomethacin results in increased activity of MPO protein]
CTD
PMID:11686837 PMID:11991626 PMID:18306037
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mtss2
MTSS I-BAR domain containing 2
increases expression
ISO
Ampicillin results in increased expression of MTSS2 mRNA
CTD
PMID:21632981
NCBI chr19:38,692,793...38,714,575
Ensembl chr19:38,693,194...38,713,507
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein]
CTD
PMID:35390362
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Myh14
myosin heavy chain 14
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MYH14 protein
CTD
PMID:30545405
NCBI chr 1:95,096,266...95,158,861
Ensembl chr 1:95,096,266...95,158,836
G
Ndufa13
NADH:ubiquinone oxidoreductase subunit A13
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFA13 protein
CTD
PMID:30545405
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein
CTD
PMID:30545405
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
G
Nherf2
NHERF family PDZ scaffold protein 2
increases expression
ISO
Ampicillin results in increased expression of NHERF2 mRNA
CTD
PMID:21632981
NCBI chr10:13,662,461...13,672,975
Ensembl chr10:13,662,461...13,673,049
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; Ampicillin inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]
CTD
PMID:11686837 PMID:12568917 PMID:15610444 PMID:16944022 PMID:18306037 PMID:21893697 More...
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npc2
NPC intracellular cholesterol transporter 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of NPC2 protein
CTD
PMID:30545405
NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Ampicillin results in increased expression of NQO1 mRNA
CTD
PMID:22609641
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Ocln
occludin
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein]
CTD
PMID:35390362
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Pa2g4
proliferation-associated 2G4
increases expression
ISO
Ampicillin results in increased expression of PA2G4 mRNA
CTD
PMID:21632981
NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
G
Pabpc1l
poly(A) binding protein, cytoplasmic 1-like
decreases expression
ISO
Ampicillin results in decreased expression of PABPC1L mRNA
CTD
PMID:21632981
NCBI chr 3:152,692,825...152,725,997
Ensembl chr 3:152,693,700...152,725,997
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
increases expression
ISO
Ampicillin results in increased expression of PDP2 mRNA
CTD
PMID:21632981
NCBI chr19:386,408...394,068
Ensembl chr19:386,406...394,074
G
Pdxkl1
pyridoxal kinase like 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PDXK protein
CTD
PMID:30545405
NCBI chr20:10,162,934...10,192,572
Ensembl chr20:10,164,099...10,192,739
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
increases expression
ISO
Ampicillin results in increased expression of PFKFB3 mRNA
CTD
PMID:21632981
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Pfn1
profilin 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PFN1 protein
CTD
PMID:30545405
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Pgam1
phosphoglycerate mutase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PGAM1 protein
CTD
PMID:30545405
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgc
progastricsin
increases expression
ISO
Ampicillin results in increased expression of PGC mRNA
CTD
PMID:21632981
NCBI chr 9:13,257,462...13,265,682
Ensembl chr 9:13,257,462...13,265,682
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Ampicillin results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Pir
pirin
increases expression
ISO
Ampicillin results in increased expression of PIR mRNA
CTD
PMID:22609641
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pkm
pyruvate kinase M1/2
increases expression
ISO
Ampicillin results in increased expression of PKM mRNA
CTD
PMID:21632981
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Plppr1
phospholipid phosphatase related 1
increases expression
ISO
Ampicillin results in increased expression of PLPPR1 mRNA
CTD
PMID:21632981
NCBI chr 5:63,437,457...63,725,286
Ensembl chr 5:63,437,816...63,763,835
G
Pmm2
phosphomannomutase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PMM2 protein
CTD
PMID:30545405
NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098
G
Pon1
paraoxonase 1
decreases activity
ISO
Ampicillin results in decreased activity of PON1 protein
CTD
PMID:16880604 PMID:31581362
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CA protein
CTD
PMID:30545405
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CB protein
CTD
PMID:30545405
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CC protein
CTD
PMID:30545405
NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553
G
Psma3
proteasome 20S subunit alpha 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PSMA3 protein
CTD
PMID:30545405
NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:89,483,727...89,504,965
G
Ptgr1
prostaglandin reductase 1
decreases expression
ISO
Ampicillin results in decreased expression of PTGR1 mRNA
CTD
PMID:21632981
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; Ampicillin inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA]
CTD
PMID:15610444 PMID:21893697
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptms
parathymosin
increases expression
ISO
Ampicillin results in increased expression of PTMS mRNA
CTD
PMID:21632981
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
G
Ralb
RAS like proto-oncogene B
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RALB protein
CTD
PMID:30545405
NCBI chr13:30,588,036...30,624,199
Ensembl chr13:30,588,033...30,624,202
G
Ran
RAN, member RAS oncogene family
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RAN protein
CTD
PMID:30545405
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA protein]
CTD
PMID:35390362
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rgcc
regulator of cell cycle
increases expression
ISO
Ampicillin results in increased expression of RGCC mRNA
CTD
PMID:21632981
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
G
Rida
reactive intermediate imine deaminase A homolog
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RIDA protein
CTD
PMID:30545405
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
G
Rpl30
ribosomal protein L30
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein
CTD
PMID:30545405
NCBI chr 7:65,648,266...65,651,401
Ensembl chr 7:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363
G
Rpn2
ribophorin II
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPN2 protein
CTD
PMID:30545405
NCBI chr 3:145,941,787...145,989,271
Ensembl chr 3:145,941,839...145,989,543
G
Rps23
ribosomal protein S23
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS23 protein
CTD
PMID:30545405
NCBI chr 2:22,079,339...22,080,909
Ensembl chr 2:22,079,302...22,080,918
G
Rps27l
ribosomal protein S27-like
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS27L protein
CTD
PMID:30545405
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
RT1-DMb
RT1 class II, locus DMb
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RT1-DMB protein
CTD
PMID:30545405
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
S100a10
S100 calcium binding protein A10
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A10 protein
CTD
PMID:30545405
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a11
S100 calcium binding protein A11
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein
CTD
PMID:30545405
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a9
S100 calcium binding protein A9
increases expression
ISO
Ampicillin results in increased expression of S100A9 mRNA
CTD
PMID:24747151
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Samd1
sterile alpha motif domain containing 1
increases expression
ISO
Ampicillin results in increased expression of SAMD1 mRNA
CTD
PMID:21632981
NCBI chr19:24,151,136...24,154,475
Ensembl chr19:24,151,128...24,154,488
G
Scarb2
scavenger receptor class B, member 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of SCARB2 protein
CTD
PMID:30545405
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
G
Serpinb6a
serpin family B member 6A
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SERPINB6 protein
CTD
PMID:30545405
NCBI chr17:30,871,468...30,989,703
Ensembl chr17:30,871,468...31,014,427
G
Sgk2
serum/glucocorticoid regulated kinase 2
decreases expression
ISO
Ampicillin results in decreased expression of SGK2 mRNA
CTD
PMID:21632981
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
G
Shmt2
serine hydroxymethyltransferase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SHMT2 protein
CTD
PMID:30545405
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
G
Slc1a2
solute carrier family 1 member 2
increases expression
ISO
Ampicillin results in increased expression of SLC1A2 protein
CTD
PMID:17138558
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc22a15
solute carrier family 22, member 15
decreases expression
ISO
Ampicillin results in decreased expression of SLC22A15 mRNA
CTD
PMID:21632981
NCBI chr 2:189,298,836...189,359,902
Ensembl chr 2:189,298,832...189,358,792
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SLC22A7 mRNA
CTD
PMID:36464106
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Ampicillin binds to and results in decreased activity of SLC25A20 protein; Ampicillin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Slc2a3
solute carrier family 2 member 3
increases expression
ISO
Ampicillin results in increased expression of SLC2A3 mRNA
CTD
PMID:21632981
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc3a1
solute carrier family 3 member 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SLC3A1 protein
CTD
PMID:30545405
NCBI chr 6:9,608,169...9,641,881
Ensembl chr 6:9,608,178...9,641,907
G
Slc6a14
solute carrier family 6 member 14
increases expression
ISO
Ampicillin results in increased expression of SLC6A14 mRNA
CTD
PMID:21632981
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Slc6a8
solute carrier family 6 member 8
increases expression
ISO
Ampicillin results in increased expression of SLC6A8 mRNA
CTD
PMID:21632981
NCBI chr X:151,384,675...151,393,979
Ensembl chr X:151,384,675...151,393,979
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
Ampicillin results in decreased expression of SLC7A11 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Smim14
small integral membrane protein 14
decreases expression
ISO
Ampicillin results in decreased expression of SMIM14 mRNA
CTD
PMID:21632981
NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760
G
Smpd2
sphingomyelin phosphodiesterase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SMPD2 protein
CTD
PMID:30545405
NCBI chr20:44,986,229...44,989,343
Ensembl chr20:44,986,231...44,989,441
G
Sqle
squalene epoxidase
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SQLE mRNA
CTD
PMID:36464106
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA
CTD
PMID:36464106
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF2 mRNA
CTD
PMID:36464106
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Srxn1
sulfiredoxin 1
decreases expression
ISO
Ampicillin results in decreased expression of SRXN1 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Tagln
transgelin
increases expression
ISO
Ampicillin results in increased expression of TAGLN mRNA
CTD
PMID:21632981
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tars1
threonyl-tRNA synthetase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TARS1 protein
CTD
PMID:30545405
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Timp1
TIMP metallopeptidase inhibitor 1
decreases expression
ISO
Ampicillin results in decreased expression of TIMP1 mRNA
CTD
PMID:21632981
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tjp1
tight junction protein 1
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]
CTD
PMID:35390362
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 protein]; TLR4 gene mutant form results in decreased susceptibility to [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin]
CTD
PMID:35390362
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tm9sf2
transmembrane 9 superfamily member 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TM9SF2 protein
CTD
PMID:30545405
NCBI chr15:99,201,556...99,254,054
Ensembl chr15:99,201,489...99,254,049
G
Tmed10
transmembrane p24 trafficking protein 10
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TMED10 protein
CTD
PMID:30545405
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tnf
tumor necrosis factor
multiple interactions
EXP ISO
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]] [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of TNF protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TNF mRNA]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein]
CTD
PMID:21893697 PMID:31442584 PMID:35390362
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tpm4
tropomyosin 4
increases expression
ISO
Ampicillin results in increased expression of TPM4 mRNA
CTD
PMID:21632981
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Traf6
TNF receptor associated factor 6
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 protein]
CTD
PMID:35390362
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Trim16
tripartite motif-containing 16
increases expression
ISO
Ampicillin results in increased expression of TRIM16 mRNA
CTD
PMID:22609641
NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907
G
Ttyh3
tweety family member 3
increases expression
ISO
Ampicillin results in increased expression of TTYH3 mRNA
CTD
PMID:21632981
NCBI chr12:13,996,831...14,025,457
Ensembl chr12:13,997,045...14,025,459
G
Tubal3
tubulin, alpha-like 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein
CTD
PMID:30545405
NCBI chr17:66,323,733...66,332,423
Ensembl chr17:66,323,733...66,335,355
G
Tubb1
tubulin, beta 1 class VI
increases expression
ISO
Ampicillin results in increased expression of TUBB1 mRNA
CTD
PMID:21632981
NCBI chr 3:163,247,990...163,257,460
Ensembl chr 3:163,247,967...163,256,063
G
Tube1
tubulin, epsilon 1
decreases expression
ISO
Ampicillin results in decreased expression of TUBE1 mRNA
CTD
PMID:21632981
NCBI chr20:42,552,390...42,570,324
Ensembl chr20:42,552,437...42,570,314
G
Twf1
twinfilin actin-binding protein 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TWF1 protein
CTD
PMID:30545405
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
G
Txndc5
thioredoxin domain containing 5
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein
CTD
PMID:30545405
NCBI chr17:26,289,880...26,318,025
Ensembl chr17:26,289,880...26,318,025
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein
CTD
PMID:30545405
NCBI chr 8:109,589,735...109,601,481
Ensembl chr 8:109,589,706...109,601,480
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRFS1 protein
CTD
PMID:30545405
NCBI chr17:33,977,908...33,982,478
Ensembl chr17:33,977,921...33,982,479
G
Uqcrh
ubiquinol-cytochrome c reductase hinge protein
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein
CTD
PMID:30545405
NCBI chr 5:129,545,978...129,554,173
Ensembl chr 5:129,545,984...129,554,242
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]]
CTD
PMID:21893697
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vldlr
very low density lipoprotein receptor
decreases expression
ISO
Ampicillin results in decreased expression of VLDLR mRNA
CTD
PMID:21632981
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of ABCB11 mRNA
CTD
PMID:34767876
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA
CTD
PMID:34767876
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Casp3
caspase 3
increases activity
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP3 protein
CTD
PMID:30273099
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP9 protein
CTD
PMID:30273099
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cycs
cytochrome c, somatic
increases secretion
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased secretion of CYCS protein
CTD
PMID:30273099
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA
CTD
PMID:34767876
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA
CTD
PMID:34767876
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP8B1 mRNA
CTD
PMID:34767876
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Fgf19
fibroblast growth factor 19
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA
CTD
PMID:34767876
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of G6PD mRNA
CTD
PMID:34767876
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA
CTD
PMID:34767876
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA
CTD
PMID:34767876
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Ggt1
gamma-glutamyltransferase 1
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GGT1 protein
CTD
PMID:34767876
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Got1
glutamic-oxaloacetic transaminase 1
increases activity
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased activity of GOT1 protein
CTD
PMID:30273099
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpt
glutamic--pyruvic transaminase
increases activity
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased activity of GPT protein
CTD
PMID:30273099
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA
CTD
PMID:34767876
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GSR mRNA
CTD
PMID:34767876
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Me1
malic enzyme 1
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of ME1 mRNA
CTD
PMID:34767876
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of NR0B2 mRNA
CTD
PMID:34767876
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Slc10a1
solute carrier family 10 member 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC10A1 mRNA
CTD
PMID:34767876
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc51a
solute carrier family 51 member A
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA
CTD
PMID:34767876
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA
CTD
PMID:34767876
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Tkt
transketolase
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of TKT mRNA
CTD
PMID:34767876
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of TXNRD1 mRNA
CTD
PMID:34767876
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
ISO
Aztreonam results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
ISO
Aztreonam results in increased expression of ABCG5 mRNA
CTD
PMID:24657338
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
increases expression
ISO
Aztreonam results in increased expression of ABCG8 mRNA
CTD
PMID:24657338
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
decreases expression
ISO
Aztreonam results in decreased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
increases expression
ISO
Aztreonam results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
RT1-Ha
RT1 class II, locus Ha
affects expression
ISO
Aztreonam affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
Slc10a1
solute carrier family 10 member 1
increases expression
ISO
Aztreonam results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc10a2
solute carrier family 10 member 2
decreases expression
ISO
Aztreonam results in decreased expression of SLC10A2 mRNA
CTD
PMID:24657338
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Slc51b
SLC51 subunit beta
decreases expression
ISO
Aztreonam results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Abcc2
ATP binding cassette subfamily C member 2
increases activity multiple interactions
EXP ISO
Penicillin G results in increased activity of ABCC2 protein Penicillin G promotes the reaction [ABCC2 protein affects the transport of estradiol-17 beta-glucuronide]
CTD
PMID:12702717 PMID:15904671
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Penicillin G
CTD
PMID:17939016
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of ACACA mRNA Penicillin G results in increased expression of ACACA mRNA
CTD
PMID:27503388
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acly
ATP citrate lyase
increases expression multiple interactions
ISO
Penicillin G results in increased expression of ACLY mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of ACLY mRNA
CTD
PMID:27503388
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
G
Afp
alpha-fetoprotein
affects expression decreases expression
ISO
Penicillin G affects the expression of AFP mRNA Penicillin G results in decreased expression of AFP mRNA
CTD
PMID:24737281 PMID:25137620 PMID:26272751
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Anxa8
annexin A8
decreases expression
ISO
Penicillin G results in decreased expression of ANXA8 mRNA
CTD
PMID:24737281
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
G
Atf3
activating transcription factor 3
increases expression
ISO
Penicillin G results in increased expression of ATF3 mRNA
CTD
PMID:27965148
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CCL2 mRNA Penicillin G results in increased expression of CCL2 mRNA
CTD
PMID:27503388
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CCR2 mRNA
CTD
PMID:27503388
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd36
CD36 molecule
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CD36 mRNA Penicillin G results in increased expression of CD36 mRNA
CTD
PMID:27503388
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd86
CD86 molecule
increases expression
ISO
Penicillin G results in increased expression of CD86 protein
CTD
PMID:19665512
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cer1
cerberus 1, DAN family BMP antagonist
increases expression
ISO
Penicillin G results in increased expression of CER1 mRNA
CTD
PMID:26272751
NCBI chr 5:97,306,427...97,309,783
Ensembl chr 5:97,306,431...97,309,783
G
Ces1d
carboxylesterase 1D
increases expression
ISO
Penicillin G results in increased expression of CES1 mRNA
CTD
PMID:22609641
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CPT1A mRNA
CTD
PMID:27503388
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Crp
C-reactive protein
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CRP mRNA
CTD
PMID:27503388
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cs
citrate synthase
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CS mRNA Penicillin G results in increased expression of CS mRNA
CTD
PMID:27503388
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Dcn
decorin
decreases expression
ISO
Penicillin G results in decreased expression of DCN mRNA
CTD
PMID:24737281
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Defb1
defensin beta 1
decreases expression multiple interactions
ISO
Penicillin G results in decreased expression of DEFB1 mRNA [Penicillin G co-treated with Erythromycin] results in decreased expression of DEFB1 mRNA
CTD
PMID:27503388
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Dgat1
diacylglycerol O-acyltransferase 1
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of DGAT1 mRNA
CTD
PMID:27503388
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dgat2
diacylglycerol O-acyltransferase 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of DGAT2 mRNA
CTD
PMID:27503388
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Fabp1
fatty acid binding protein 1
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of FABP1 mRNA
CTD
PMID:27503388
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fasn
fatty acid synthase
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of FASN mRNA Penicillin G results in increased expression of FASN mRNA
CTD
PMID:27503388
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Frzb
frizzled-related protein
decreases expression
ISO
Penicillin G results in decreased expression of FRZB mRNA
CTD
PMID:24737281
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Penicillin G results in increased expression of GCLM mRNA
CTD
PMID:22609641
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
increases expression multiple interactions
ISO
Penicillin G results in increased expression of GPAM mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of GPAM mRNA
CTD
PMID:27503388
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Hdac7
histone deacetylase 7
increases expression
ISO
Penicillin G results in increased expression of HDAC7 mRNA
CTD
PMID:26272751
NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072
G
Ifng
interferon gamma
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of IFNG mRNA Penicillin G results in increased expression of IFNG mRNA
CTD
PMID:27503388
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf2
insulin-like growth factor 2
decreases expression
ISO
Penicillin G results in decreased expression of IGF2 mRNA
CTD
PMID:24737281
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
ISO
Penicillin G results in decreased expression of IGFBP5 mRNA
CTD
PMID:24737281
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Il18
interleukin 18
increases expression
ISO
Penicillin G results in increased expression of IL18 protein
CTD
PMID:23063874
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases expression multiple interactions
ISO
Penicillin G results in increased expression of IL1A mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of IL1A mRNA
CTD
PMID:27503388
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
ISO
Penicillin G results in increased expression of IL1B mRNA
CTD
PMID:22609641
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of IL6 mRNA
CTD
PMID:27503388
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Penicillin G results in increased expression of JUN mRNA
CTD
PMID:26272751
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kdr
kinase insert domain receptor
increases expression decreases expression
ISO
Penicillin G results in increased expression of KDR mRNA Penicillin G results in decreased expression of KDR mRNA
CTD
PMID:25137620 PMID:26272751
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Lbp
lipopolysaccharide binding protein
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of LBP mRNA
CTD
PMID:27503388
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Mesp1
mesoderm posterior bHLH transcription factor 1
decreases expression
ISO
Penicillin G results in decreased expression of MESP1 mRNA
CTD
PMID:26272751
NCBI chr 1:133,738,357...133,739,875
Ensembl chr 1:133,738,357...133,739,875
G
Mmp1
matrix metallopeptidase 1
decreases expression
ISO
Penicillin G results in decreased expression of MMP1 mRNA
CTD
PMID:24737281
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mttp
microsomal triglyceride transfer protein
increases expression multiple interactions
ISO
Penicillin G results in increased expression of MTTP mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of MTTP mRNA
CTD
PMID:27503388
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Muc2
mucin 2, oligomeric mucus/gel-forming
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of MUC2 mRNA
CTD
PMID:27503388
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
Penicillin G results in increased expression of MYC mRNA
CTD
PMID:26272751
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nefm
neurofilament medium chain
affects expression
ISO
Penicillin G affects the expression of NEFM mRNA
CTD
PMID:25137620
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Nes
nestin
increases expression affects expression
EXP ISO
Penicillin G results in increased expression of NES protein Penicillin G affects the expression of NES mRNA
CTD
PMID:16137769 PMID:16369854 PMID:25137620
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of NFKB1 mRNA Penicillin G results in increased expression of NFKB1 mRNA
CTD
PMID:27503388
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Penicillin G results in increased expression of NQO1 mRNA
CTD
PMID:22609641
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Penicillin G results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Pir
pirin
increases expression
ISO
Penicillin G results in increased expression of PIR mRNA
CTD
PMID:22609641
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pnpla6
patatin-like phospholipase domain containing 6
decreases expression
ISO
Penicillin G results in decreased expression of PNPLA6 mRNA
CTD
PMID:25137620
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Reg3g
regenerating family member 3 gamma
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of REG3G mRNA
CTD
PMID:27503388
NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:110,924,168...110,926,723
G
Retnlb
resistin like beta
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of RETNLB mRNA
CTD
PMID:27503388
NCBI chr11:51,983,482...51,985,368
Ensembl chr11:51,983,483...51,985,368
G
Scd
stearoyl-CoA desaturase
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of SCD1 mRNA Penicillin G results in increased expression of SCD1 mRNA
CTD
PMID:27503388
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Shh
sonic hedgehog signaling molecule
increases expression
ISO
Penicillin G results in increased expression of SHH mRNA
CTD
PMID:26272751
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Slc22a12
solute carrier family 22 member 12
multiple interactions
ISO
Potassium promotes the reaction [SLC22A12 protein results in increased uptake of Penicillin G]
CTD
PMID:15284287
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
G
Slc22a20
solute carrier family 22 member 20
multiple interactions
ISO
Penicillin G inhibits the reaction [SLC22A20 protein results in increased uptake of estrone sulfate]
CTD
PMID:16478971
NCBI chr 1:203,257,374...203,273,854
Ensembl chr 1:203,257,374...203,273,822
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
Penicillin G inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:11602689
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
multiple interactions increases uptake
EXP ISO
Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Famotidine]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Ranitidine]; Probenecid inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G]; tranilast inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G] resveratrol inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G]
CTD
PMID:10224140 PMID:15319347 PMID:17255469 PMID:27377006 PMID:35019195
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc27a2
solute carrier family 27 member 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of SLC27A2 mRNA
CTD
PMID:27503388
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slco3a1
solute carrier organic anion transporter family, member 3a1
multiple interactions
ISO
Penicillin G promotes the reaction [SLCO3A1 protein results in increased uptake of simvastatin acid]
CTD
PMID:28887287
NCBI chr 1:128,106,232...128,388,043
Ensembl chr 1:128,106,228...128,387,925
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of SREBF1 mRNA
CTD
PMID:27503388
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of TLR4 mRNA
CTD
PMID:27503388
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of TNF mRNA Penicillin G results in increased expression of TNF mRNA
CTD
PMID:27503388
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trim16
tripartite motif-containing 16
increases expression
ISO
Penicillin G results in increased expression of TRIM16 mRNA
CTD
PMID:22609641
NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907
G
Ttr
transthyretin
decreases expression
ISO
Penicillin G results in decreased expression of TTR mRNA
CTD
PMID:24737281
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Wnt3
Wnt family member 3
increases expression
ISO
Penicillin G results in increased expression of WNT3 mRNA
CTD
PMID:26272751
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
G
Apeh
acylaminoacyl-peptide hydrolase
multiple interactions decreases activity
ISO
Carbapenems inhibits the reaction [APEH protein results in increased metabolism of valproic acid glucuronide] Carbapenems results in decreased activity of APEH protein
CTD
PMID:20551238
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
Cefaclor inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Cefaclor results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Cefaclor results in increased expression of CYP3A4 mRNA; Cefaclor results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
Cefaclor inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Cefaclor Cefaclor inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Cefadroxil results in increased expression of CYP3A4 mRNA; Cefadroxil results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
affects expression
ISO
Cefadroxil affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Aadac
arylacetamide deacetylase
increases expression
EXP
Cephaloridine results in increased expression of AADAC mRNA
CTD
PMID:18500788
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
EXP
Cephaloridine results in decreased expression of AASS mRNA
CTD
PMID:18500788
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
increases expression
EXP
Cephaloridine results in increased expression of ABCB1B mRNA
CTD
PMID:18500788
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
EXP
Cephaloridine results in increased expression of ABCC2 mRNA
CTD
PMID:18500788
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Acmsd
aminocarboxymuconate semialdehyde decarboxylase
decreases expression
EXP
Cephaloridine results in decreased expression of ACMSD mRNA
CTD
PMID:18500788
NCBI chr13:39,200,412...39,245,954
Ensembl chr13:39,200,314...39,245,209
G
Acot9
acyl-CoA thioesterase 9
increases expression
EXP
Cephaloridine results in increased expression of ACOT9 mRNA
CTD
PMID:18500788
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
G
Acsm5
acyl-CoA synthetase medium-chain family member 5
decreases expression
EXP
Cephaloridine results in decreased expression of ACSM5 mRNA
CTD
PMID:18500788
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
G
Adam8
ADAM metallopeptidase domain 8
decreases expression
EXP
Cephaloridine results in decreased expression of ADAM8 mRNA
CTD
PMID:18500788
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adgre1
adhesion G protein-coupled receptor E1
increases expression
EXP
Cephaloridine results in increased expression of ADGRE1 mRNA
CTD
PMID:18500788
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
G
Adora2a
adenosine A2a receptor
increases expression
EXP
Cephaloridine results in increased expression of ADORA2A mRNA
CTD
PMID:18500788
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adra1d
adrenoceptor alpha 1D
increases expression
EXP
Cephaloridine results in increased expression of ADRA1D mRNA
CTD
PMID:18500788
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
G
Aftph
aftiphilin
decreases expression
EXP
Cephaloridine results in decreased expression of AFTPH mRNA
CTD
PMID:18500788
NCBI chr14:94,871,429...94,925,625
Ensembl chr14:94,871,429...94,925,376
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
EXP
Cephaloridine results in increased expression of AKR1B1 mRNA
CTD
PMID:18172885
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression
EXP
Cephaloridine results in increased expression of AKR1D1 mRNA
CTD
PMID:18172885
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Alas1
5'-aminolevulinate synthase 1
increases expression
EXP
Cephaloridine results in increased expression of ALAS1 mRNA
CTD
PMID:18500788
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
increases expression
EXP
Cephaloridine results in increased expression of ALDH3A1 mRNA
CTD
PMID:18500788
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
increases expression
EXP
Cephaloridine results in increased expression of ALDH3B1 mRNA
CTD
PMID:18500788
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
G
Aldoa
aldolase, fructose-bisphosphate A
affects expression
EXP
Cephaloridine affects the expression of ALDOA mRNA
CTD
PMID:18172885
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Amer2
APC membrane recruitment protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of AMER2 mRNA
CTD
PMID:18500788
NCBI chr15:34,525,352...34,535,660
Ensembl chr15:34,524,542...34,528,455
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
EXP
Cephaloridine results in increased expression of AMIGO2 mRNA
CTD
PMID:18500788
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
G
Ampd1
adenosine monophosphate deaminase 1
increases expression
EXP
Cephaloridine results in increased expression of AMPD1 mRNA
CTD
PMID:18500788
NCBI chr 2:190,598,707...190,619,938
Ensembl chr 2:190,598,700...190,619,938
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
EXP
Cephaloridine results in increased expression of AMPD3 mRNA
CTD
PMID:18500788
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Angptl4
angiopoietin-like 4
increases expression
EXP
Cephaloridine results in increased expression of ANGPTL4 mRNA
CTD
PMID:18500788
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Anln
anillin, actin binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of ANLN mRNA
CTD
PMID:18500788
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
G
Anxa13
annexin A13
decreases expression
EXP
Cephaloridine results in decreased expression of ANXA13 mRNA
CTD
PMID:18500788
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
G
Anxa7
annexin A7
increases expression
EXP
Cephaloridine results in increased expression of ANXA7 mRNA
CTD
PMID:18500788
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
G
Apcs
amyloid P component, serum
decreases expression
EXP
Cephaloridine results in decreased expression of APCS mRNA
CTD
PMID:18500788
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
G
Apoa4
apolipoprotein A4
increases expression
EXP
Cephaloridine results in increased expression of APOA4 mRNA
CTD
PMID:18500788
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apob
apolipoprotein B
increases expression
EXP
Cephaloridine results in increased expression of APOB mRNA
CTD
PMID:18500788
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc2
apolipoprotein C2
increases expression
EXP
Cephaloridine results in increased expression of APOC2 mRNA
CTD
PMID:18500788
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apold1
apolipoprotein L domain containing 1
decreases expression
EXP
Cephaloridine results in decreased expression of APOLD1 mRNA
CTD
PMID:18500788
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
G
Arfgef3
ARFGEF family member 3
decreases expression
EXP
Cephaloridine results in decreased expression of ARFGEF3 mRNA
CTD
PMID:18500788
NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084
G
Arhgap35
Rho GTPase activating protein 35
decreases expression
EXP
Cephaloridine results in decreased expression of ARHGAP35 mRNA
CTD
PMID:18500788
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
G
Arid5a
AT-rich interaction domain 5A
increases expression
EXP
Cephaloridine results in increased expression of ARID5A mRNA
CTD
PMID:18500788
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
G
Asf1b
anti-silencing function 1B histone chaperone
increases expression
EXP
Cephaloridine results in increased expression of ASF1B mRNA
CTD
PMID:18500788
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Ash1l
ASH1 like histone lysine methyltransferase
decreases expression
EXP
Cephaloridine results in decreased expression of ASH1L mRNA
CTD
PMID:18500788
NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
Cephaloridine results in increased expression of ASNS mRNA
CTD
PMID:18500788
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atad1
ATPase family, AAA domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of ATAD1 mRNA
CTD
PMID:18500788
NCBI chr 1:230,544,227...230,610,524
Ensembl chr 1:230,544,047...230,596,548
G
Atad2
ATPase family, AAA domain containing 2
increases expression
EXP
Cephaloridine results in increased expression of ATAD2 mRNA
CTD
PMID:18500788
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
decreases expression
EXP
Cephaloridine results in decreased expression of ATF3 mRNA
CTD
PMID:18500788
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atl1
atlastin GTPase 1
increases expression
EXP
Cephaloridine results in increased expression of ATL1 mRNA
CTD
PMID:18500788
NCBI chr 6:88,377,168...88,475,242
Ensembl chr 6:88,377,239...88,475,204
G
Atp11c
ATPase phospholipid transporting 11C
decreases expression
EXP
Cephaloridine results in decreased expression of ATP11C mRNA
CTD
PMID:18500788
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp12a
ATPase H+/K+ transporting non-gastric alpha2 subunit
increases expression
EXP
Cephaloridine results in increased expression of ATP12A mRNA
CTD
PMID:18500788
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
G
Aurkb
aurora kinase B
decreases expression
EXP
Cephaloridine results in decreased expression of AURKB mRNA
CTD
PMID:18500788
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
B3galt2
Beta-1,3-galactosyltransferase 2
decreases expression
EXP
Cephaloridine results in decreased expression of B3GALT2 mRNA
CTD
PMID:18500788
NCBI chr13:55,389,406...55,398,419
Ensembl chr13:55,389,406...55,398,419
G
B3gnt7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
decreases expression
EXP
Cephaloridine results in decreased expression of B3GNT7 mRNA
CTD
PMID:18500788
NCBI chr 9:86,956,220...86,960,171
Ensembl chr 9:86,956,220...86,960,170
G
Bag3
BAG cochaperone 3
increases expression
EXP
Cephaloridine results in increased expression of BAG3 mRNA
CTD
PMID:18500788
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Bak1
BCL2-antagonist/killer 1
increases expression
EXP
Cephaloridine results in increased expression of BAK1 mRNA
CTD
PMID:18500788
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bard1
BRCA1 associated RING domain 1
increases expression
EXP
Cephaloridine results in increased expression of BARD1 mRNA
CTD
PMID:18500788
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Batf
basic leucine zipper ATF-like transcription factor
increases expression
EXP
Cephaloridine results in increased expression of BATF mRNA
CTD
PMID:18500788
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
G
Bcl2l1
Bcl2-like 1
affects expression
EXP
Cephaloridine affects the expression of BCL2L1 mRNA
CTD
PMID:18172885
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bex2
brain expressed X-linked 2
increases expression
EXP
Cephaloridine results in increased expression of BEX1 mRNA
CTD
PMID:18500788
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
G
Bex4
brain expressed, X-linked 4
increases expression
EXP
Cephaloridine results in increased expression of BEX4 mRNA
CTD
PMID:18500788
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
EXP
Cephaloridine results in increased expression of BHLHE41 mRNA
CTD
PMID:18500788
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
EXP
Cephaloridine results in increased expression of BIRC3 mRNA
CTD
PMID:18500788
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Blvrb
biliverdin reductase B
increases expression
EXP
Cephaloridine results in increased expression of BLVRB mRNA
CTD
PMID:18500788
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bpi
bactericidal/permeability-increasing protein
increases expression
EXP
Cephaloridine results in increased expression of BPI mRNA
CTD
PMID:18500788
NCBI chr 3:146,909,626...146,936,487
Ensembl chr 3:146,909,629...146,936,221
G
Brip1
BRCA1 interacting helicase 1
increases expression
EXP
Cephaloridine results in increased expression of BRIP1 mRNA
CTD
PMID:18500788
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
G
Bsnd
barttin CLCNK type accessory subunit beta
increases expression
EXP
Cephaloridine results in increased expression of BSND mRNA
CTD
PMID:18500788
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
G
Btg2
BTG anti-proliferation factor 2
decreases expression
EXP
Cephaloridine results in decreased expression of BTG2 mRNA
CTD
PMID:18500788
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
EXP
Cephaloridine results in decreased expression of BUB1B mRNA
CTD
PMID:18500788
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
C10h16orf89
similar to human chromosome 16 open reading frame 89
increases expression
EXP
Cephaloridine results in increased expression of C10H16ORF89 mRNA
CTD
PMID:18500788
NCBI chr10:10,361,909...10,371,046
Ensembl chr10:10,361,948...10,371,046
G
C1qtnf1
C1q and TNF related 1
increases expression
EXP
Cephaloridine results in increased expression of C1QTNF1 mRNA
CTD
PMID:18500788
NCBI chr10:103,660,319...103,681,662
Ensembl chr10:103,660,327...103,681,660
G
C5
complement C5
decreases expression
EXP
Cephaloridine results in decreased expression of C5 mRNA
CTD
PMID:18500788
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C6
complement C6
increases expression
EXP
Cephaloridine results in increased expression of C6 mRNA
CTD
PMID:18500788
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
increases expression
EXP
Cephaloridine results in increased expression of CACNA1H mRNA
CTD
PMID:18500788
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cacng3
calcium voltage-gated channel auxiliary subunit gamma 3
increases expression
EXP
Cephaloridine results in increased expression of CACNG3 mRNA
CTD
PMID:18500788
NCBI chr 1:177,201,361...177,297,019
Ensembl chr 1:177,201,288...177,297,024
G
Calb1
calbindin 1
increases expression
EXP
Cephaloridine results in increased expression of CALB1 mRNA
CTD
PMID:18500788
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Calb2
calbindin 2
decreases expression
EXP
Cephaloridine results in decreased expression of CALB2 mRNA
CTD
PMID:18500788
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Calr
calreticulin
increases expression
EXP
Cephaloridine results in increased expression of CALR mRNA
CTD
PMID:18172885
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Camkv
CaM kinase-like vesicle-associated
increases expression
EXP
Cephaloridine results in increased expression of CAMKV mRNA
CTD
PMID:18500788
NCBI chr 8:108,626,821...108,641,169
Ensembl chr 8:108,626,821...108,641,169
G
Canx
calnexin
increases expression
EXP
Cephaloridine results in increased expression of CANX mRNA
CTD
PMID:18172885
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Cat
catalase
affects expression
EXP
Cephaloridine affects the expression of CAT protein
CTD
PMID:9933756
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccdc113
coiled-coil domain containing 113
increases expression
EXP
Cephaloridine results in increased expression of CCDC113 mRNA
CTD
PMID:18500788
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
G
Ccl17
C-C motif chemokine ligand 17
increases expression
EXP
Cephaloridine results in increased expression of CCL17 mRNA
CTD
PMID:18500788
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl19
C-C motif chemokine ligand 19
increases expression
EXP
Cephaloridine results in increased expression of CCL19 mRNA
CTD
PMID:18500788
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl20
C-C motif chemokine ligand 20
increases expression
EXP
Cephaloridine results in increased expression of CCL20 mRNA
CTD
PMID:18500788
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl28
C-C motif chemokine ligand 28
increases expression
EXP
Cephaloridine results in increased expression of CCL28 mRNA
CTD
PMID:18500788
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
EXP
Cephaloridine results in decreased expression of CCL3 mRNA
CTD
PMID:18500788
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
EXP
Cephaloridine results in decreased expression of CCL4 mRNA
CTD
PMID:18500788
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccn2
cellular communication network factor 2
decreases expression
EXP
Cephaloridine results in decreased expression of CCN2 mRNA
CTD
PMID:18500788
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
decreases expression
EXP
Cephaloridine results in decreased expression of CCNA2 mRNA
CTD
PMID:18500788
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
EXP
Cephaloridine results in decreased expression of CCNB1 mRNA
CTD
PMID:18500788
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
decreases expression
EXP
Cephaloridine results in decreased expression of CCNB2 mRNA
CTD
PMID:18500788
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccne1
cyclin E1
increases expression
EXP
Cephaloridine results in increased expression of CCNE1 mRNA
CTD
PMID:18500788
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
increases expression
EXP
Cephaloridine results in increased expression of CCNE2 mRNA
CTD
PMID:18500788
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Cd52
CD52 molecule
decreases expression
EXP
Cephaloridine results in decreased expression of CD52 mRNA
CTD
PMID:18500788
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
G
Cd72
Cd72 molecule
increases expression
EXP
Cephaloridine results in increased expression of CD72 mRNA
CTD
PMID:18500788
NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725
G
Cd86
CD86 molecule
increases expression
EXP
Cephaloridine results in increased expression of CD86 mRNA
CTD
PMID:18500788
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdc42
cell division cycle 42
decreases expression
EXP
Cephaloridine results in decreased expression of CDC42 mRNA
CTD
PMID:18172885
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdc45
cell division cycle 45
increases expression
EXP
Cephaloridine results in increased expression of CDC45 mRNA
CTD
PMID:18500788
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
G
Cdc6
cell division cycle 6
increases expression
EXP
Cephaloridine results in increased expression of CDC6 mRNA
CTD
PMID:18500788
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdca2
cell division cycle associated 2
decreases expression
EXP
Cephaloridine results in decreased expression of CDCA2 mRNA
CTD
PMID:18500788
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of CDK1 mRNA
CTD
PMID:18500788
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdkl1
cyclin dependent kinase like 1
decreases expression
EXP
Cephaloridine results in decreased expression of CDKL1 mRNA
CTD
PMID:18500788
NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
EXP
Cephaloridine results in decreased expression of CDKN1A mRNA
CTD
PMID:18500788
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
EXP
Cephaloridine results in decreased expression of CDKN1B mRNA
CTD
PMID:18500788
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdt1
chromatin licensing and DNA replication factor 1
increases expression
EXP
Cephaloridine results in increased expression of CDT1 mRNA
CTD
PMID:18500788
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Ceacam16
CEA cell adhesion molecule 16, tectorial membrane component
increases expression
EXP
Cephaloridine results in increased expression of CEACAM16 mRNA
CTD
PMID:18500788
NCBI chr 1:79,514,975...79,524,871
Ensembl chr 1:79,514,975...79,524,871
G
Cenpk
centromere protein K
increases expression
EXP
Cephaloridine results in increased expression of CENPK mRNA
CTD
PMID:18500788
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
G
Cenpq
centromere protein Q
increases expression
EXP
Cephaloridine results in increased expression of CENPQ mRNA
CTD
PMID:18500788
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
G
Cesl1
carboxylesterase-like 1
decreases expression
EXP
Cephaloridine results in decreased expression of CESL1 mRNA
CTD
PMID:18500788
NCBI chr19:22,670,709...23,006,329
Ensembl chr19:22,670,712...22,712,608
G
Chaf1a
chromatin assembly factor 1 subunit A
increases expression
EXP
Cephaloridine results in increased expression of CHAF1A mRNA
CTD
PMID:18500788
NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654
G
Chaf1b
chromatin assembly factor 1 subunit B
increases expression
EXP
Cephaloridine results in increased expression of CHAF1B mRNA
CTD
PMID:18500788
NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070
G
Chd4
chromodomain helicase DNA binding protein 4
decreases expression
EXP
Cephaloridine results in decreased expression of CHD4 mRNA
CTD
PMID:18500788
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
G
Chd6
chromodomain helicase DNA binding protein 6
decreases expression
EXP
Cephaloridine results in decreased expression of CHD6 mRNA
CTD
PMID:18500788
NCBI chr 3:149,596,509...149,757,765
Ensembl chr 3:149,596,509...149,757,755
G
Chek1
checkpoint kinase 1
increases expression
EXP
Cephaloridine results in increased expression of CHEK1 mRNA
CTD
PMID:18500788
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chst7
carbohydrate sulfotransferase 7
decreases expression
EXP
Cephaloridine results in decreased expression of CHST7 mRNA
CTD
PMID:18500788
NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840
G
Chtf18
chromosome transmission fidelity factor 18
increases expression
EXP
Cephaloridine results in increased expression of CHTF18 mRNA
CTD
PMID:18500788
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Cilp
cartilage intermediate layer protein
decreases expression
EXP
Cephaloridine results in decreased expression of CILP mRNA
CTD
PMID:18500788
NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:65,777,281...65,792,251
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
EXP
Cephaloridine results in increased expression of CITED2 mRNA
CTD
PMID:18172885
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Ckap2
cytoskeleton associated protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of CKAP2 mRNA
CTD
PMID:18500788
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Cldn14
claudin 14
increases expression
EXP
Cephaloridine results in increased expression of CLDN14 mRNA
CTD
PMID:18500788
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
G
Clstn2
calsyntenin 2
decreases expression
EXP
Cephaloridine results in decreased expression of CLSTN2 mRNA
CTD
PMID:18500788
NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731
G
Cmip
c-Maf-inducing protein
decreases expression
EXP
Cephaloridine results in decreased expression of CMIP mRNA
CTD
PMID:18500788
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
G
Cndp1
carnosine dipeptidase 1
decreases expression
EXP
Cephaloridine results in decreased expression of CNDP1 mRNA
CTD
PMID:18500788
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
G
Col4a4
collagen type IV alpha 4 chain
decreases expression
EXP
Cephaloridine results in decreased expression of COL4A4 mRNA
CTD
PMID:18500788
NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876
G
Col7a1
collagen type VII alpha 1 chain
increases expression
EXP
Cephaloridine results in increased expression of COL7A1 mRNA
CTD
PMID:18500788
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
G
Cpt1b
carnitine palmitoyltransferase 1B
increases expression
EXP
Cephaloridine results in increased expression of CPT1B mRNA
CTD
PMID:18500788
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Crabp1
cellular retinoic acid binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of CRABP1 mRNA
CTD
PMID:18500788
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
G
Crebbp
CREB binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of CREBBP mRNA
CTD
PMID:18500788
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Cry1
cryptochrome circadian regulator 1
increases expression
EXP
Cephaloridine results in increased expression of CRY1 mRNA
CTD
PMID:18500788
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
EXP
Cephaloridine results in decreased expression of CXCL1 mRNA
CTD
PMID:18500788
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
EXP
Cephaloridine results in increased expression of CXCL10 mRNA
CTD
PMID:18500788
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl13
C-X-C motif chemokine ligand 13
increases expression
EXP
Cephaloridine results in increased expression of CXCL13 mRNA
CTD
PMID:18500788
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
G
Cxcl14
C-X-C motif chemokine ligand 14
increases expression
EXP
Cephaloridine results in increased expression of CXCL14 mRNA
CTD
PMID:18500788
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
G
Cxxc4
CXXC finger protein 4
decreases expression
EXP
Cephaloridine results in decreased expression of CXXC4 mRNA
CTD
PMID:18500788
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
G
Cyb5a
cytochrome b5 type A
increases expression
EXP
Cephaloridine results in increased expression of CYB5A mRNA
CTD
PMID:18172885
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
EXP
Cephaloridine results in increased expression of CYP1B1 mRNA
CTD
PMID:18500788
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
decreases expression
EXP
Cephaloridine results in decreased expression of CYP24A1 mRNA
CTD
PMID:18500788
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression
EXP
Cephaloridine results in decreased expression of CYP2C mRNA
CTD
PMID:18500788
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
increases expression
EXP
Cephaloridine results in increased expression of CYP7B1 mRNA
CTD
PMID:18500788
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Dctpp1
dCTP pyrophosphatase 1
increases expression
EXP
Cephaloridine results in increased expression of DCTPP1 mRNA
CTD
PMID:18500788
NCBI chr 1:181,877,440...181,880,833
Ensembl chr 1:181,877,437...181,880,839
G
Dctpp1-ps2
dCTP pyrophosphatase 1, pseudogene 2
increases expression
EXP
Cephaloridine results in increased expression of DCTPP1-PS2 mRNA
CTD
PMID:18500788
NCBI chr16:1,392,967...1,393,868
G
Ddc
dopa decarboxylase
decreases expression
EXP
Cephaloridine results in decreased expression of DDC mRNA
CTD
PMID:18500788
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddit4
DNA-damage-inducible transcript 4
decreases expression
EXP
Cephaloridine results in decreased expression of DDIT4 mRNA
CTD
PMID:18500788
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddit4l
DNA-damage-inducible transcript 4-like
increases expression
EXP
Cephaloridine results in increased expression of DDIT4L mRNA
CTD
PMID:18500788
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
G
Ddx39a
DExD-box helicase 39A
increases expression
EXP
Cephaloridine results in increased expression of DDX39A mRNA
CTD
PMID:18500788
NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954
G
Ddx6
DEAD-box helicase 6
decreases expression
EXP
Cephaloridine results in decreased expression of DDX6 mRNA
CTD
PMID:18500788
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Decr2
2,4-dienoyl-CoA reductase 2
decreases expression
EXP
Cephaloridine results in decreased expression of DECR2 mRNA
CTD
PMID:18500788
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
G
Dhrs2l1
dehydrogenase/reductase member 2 like 1
increases expression
EXP
Cephaloridine results in increased expression of DHRS2L1 mRNA
CTD
PMID:18500788
NCBI chr15:28,635,197...28,638,087
Ensembl chr15:28,635,197...28,638,087
G
Dlgap1
DLG associated protein 1
increases expression
EXP
Cephaloridine results in increased expression of DLGAP1 mRNA
CTD
PMID:18500788
NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817
G
Dnah7
dynein, axonemal, heavy chain 7
decreases expression
EXP
Cephaloridine results in decreased expression of DNAH7 mRNA
CTD
PMID:18500788
NCBI chr 9:54,960,235...55,266,529
Ensembl chr 9:54,960,440...55,262,297
G
Dnah9
dynein, axonemal, heavy chain 9
decreases expression
EXP
Cephaloridine results in decreased expression of DNAH9 mRNA
CTD
PMID:18500788
NCBI chr10:50,496,174...50,864,909
Ensembl chr10:50,497,688...50,864,949
G
Dnase1l3
deoxyribonuclease 1-like 3
increases expression
EXP
Cephaloridine results in increased expression of DNASE1L3 mRNA
CTD
PMID:18500788
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
increases expression
EXP
Cephaloridine results in increased expression of DNPH1 mRNA
CTD
PMID:18500788
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Donson
DNA replication fork stabilization factor DONSON
increases expression
EXP
Cephaloridine results in increased expression of DONSON mRNA
CTD
PMID:18500788
NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889
G
Dpf1
double PHD fingers 1
increases expression
EXP
Cephaloridine results in increased expression of DPF1 mRNA
CTD
PMID:18500788
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
G
Dscc1
DNA replication and sister chromatid cohesion 1
increases expression
EXP
Cephaloridine results in increased expression of DSCC1 mRNA
CTD
PMID:18500788
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
G
Dsg2
desmoglein 2
increases expression
EXP
Cephaloridine results in increased expression of DSG2 mRNA
CTD
PMID:18500788
NCBI chr18:11,846,207...11,904,630
Ensembl chr18:11,846,183...11,904,156
G
Dtx4
deltex E3 ubiquitin ligase 4
increases expression
EXP
Cephaloridine results in increased expression of DTX4 mRNA
CTD
PMID:18500788
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
G
Dusp6
dual specificity phosphatase 6
affects expression
EXP
Cephaloridine affects the expression of DUSP6 mRNA
CTD
PMID:18172885
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dusp7
dual specificity phosphatase 7
decreases expression
EXP
Cephaloridine results in decreased expression of DUSP7 mRNA
CTD
PMID:18500788
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
G
Dusp9
dual specificity phosphatase 9
increases expression
EXP
Cephaloridine results in increased expression of DUSP9 mRNA
CTD
PMID:18500788
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
G
E2f8
E2F transcription factor 8
increases expression
EXP
Cephaloridine results in increased expression of E2F8 mRNA
CTD
PMID:18500788
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Edrf1
erythroid differentiation regulatory factor 1
decreases expression
EXP
Cephaloridine results in decreased expression of EDRF1 mRNA
CTD
PMID:18500788
NCBI chr 1:188,441,514...188,478,743
Ensembl chr 1:188,441,634...188,478,701
G
Eef2
eukaryotic translation elongation factor 2
increases expression
EXP
Cephaloridine results in increased expression of EEF2 mRNA
CTD
PMID:18172885
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Egr1
early growth response 1
decreases expression
EXP
Cephaloridine results in decreased expression of EGR1 mRNA
CTD
PMID:18500788
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
decreases expression
EXP
Cephaloridine results in decreased expression of EGR2 mRNA
CTD
PMID:18500788
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Eif4h
eukaryotic translation initiation factor 4H
increases expression
EXP
Cephaloridine results in increased expression of EIF4H mRNA
CTD
PMID:18172885
NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
G
Elf3
E74 like ETS transcription factor 3
increases expression
EXP
Cephaloridine results in increased expression of ELF3 mRNA
CTD
PMID:18500788
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Emb
embigin
increases expression
EXP
Cephaloridine results in increased expression of EMB mRNA
CTD
PMID:18500788
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
G
Eme1
essential meiotic structure-specific endonuclease 1
decreases expression
EXP
Cephaloridine results in decreased expression of EME1 mRNA
CTD
PMID:18500788
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
G
Enc1
ectodermal-neural cortex 1
increases expression
EXP
Cephaloridine results in increased expression of ENC1 mRNA
CTD
PMID:18500788
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Eno2
enolase 2
increases expression
EXP
Cephaloridine results in increased expression of ENO2 mRNA
CTD
PMID:18500788
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Entrep1
endosomal transmembrane epsin interactor 1
increases expression
EXP
Cephaloridine results in increased expression of ENTREP1 mRNA
CTD
PMID:18500788
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
EXP
Cephaloridine results in decreased expression of ESPL1 mRNA
CTD
PMID:18500788
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Exo1
exonuclease 1
increases expression
EXP
Cephaloridine results in increased expression of EXO1 mRNA
CTD
PMID:18500788
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
F13b
coagulation factor XIII B chain
decreases expression
EXP
Cephaloridine results in decreased expression of F13B mRNA
CTD
PMID:18500788
NCBI chr13:51,130,908...51,156,383
Ensembl chr13:51,130,920...51,156,381
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression
EXP
Cephaloridine results in decreased expression of FAM111A mRNA
CTD
PMID:18500788
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
G
Fancd2
FA complementation group D2
increases expression
EXP
Cephaloridine results in increased expression of FANCD2 mRNA
CTD
PMID:18500788
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
G
Fbln1
fibulin 1
increases expression
EXP
Cephaloridine results in increased expression of FBLN1 mRNA
CTD
PMID:18500788
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbp2
fructose-bisphosphatase 2
increases expression
EXP
Cephaloridine results in increased expression of FBP2 mRNA
CTD
PMID:18500788
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
G
Fbxo5
F-box protein 5
increases expression
EXP
Cephaloridine results in increased expression of FBXO5 mRNA
CTD
PMID:18500788
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fcgr2a
Fc gamma receptor 2A
increases expression
EXP
Cephaloridine results in increased expression of FCGR2A mRNA
CTD
PMID:18500788
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fcgr2b
Fc gamma receptor 2B
increases expression
EXP
Cephaloridine results in increased expression of FCGR2B mRNA
CTD
PMID:18500788
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fcgr3a
Fc gamma receptor 3A
increases expression
EXP
Cephaloridine results in increased expression of FCGR3A mRNA
CTD
PMID:18500788
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Fcnb
ficolin B
increases expression
EXP
Cephaloridine results in increased expression of FCNB mRNA
CTD
PMID:18500788
NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151
G
Fen1
flap structure-specific endonuclease 1
increases expression
EXP
Cephaloridine results in increased expression of FEN1 mRNA
CTD
PMID:18500788
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fgb
fibrinogen beta chain
increases expression
EXP
Cephaloridine results in increased expression of FGB mRNA
CTD
PMID:18500788
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgf17
fibroblast growth factor 17
increases expression
EXP
Cephaloridine results in increased expression of FGF17 mRNA
CTD
PMID:18500788
NCBI chr15:45,711,498...45,717,622
Ensembl chr15:45,711,998...45,717,063
G
Fgl2
fibrinogen-like 2
increases expression
EXP
Cephaloridine results in increased expression of FGL2 mRNA
CTD
PMID:18500788
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Fhdc1
FH2 domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of FHDC1 mRNA
CTD
PMID:18500788
NCBI chr 2:169,790,917...169,829,580
Ensembl chr 2:169,790,947...169,827,896
G
Filip1
filamin A interacting protein 1
decreases expression
EXP
Cephaloridine results in decreased expression of FILIP1 mRNA
CTD
PMID:18500788
NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549
G
Folh1
folate hydrolase 1
decreases expression
EXP
Cephaloridine results in decreased expression of FOLH1 mRNA
CTD
PMID:18500788
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Cephaloridine results in decreased expression of FOS mRNA
CTD
PMID:18500788
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxe1
forkhead box E1
decreases expression
EXP
Cephaloridine results in decreased expression of FOXE1 mRNA
CTD
PMID:18500788
NCBI chr 5:60,630,027...60,632,835
Ensembl chr 5:60,630,027...60,632,835
G
Foxq1
forkhead box Q1
increases expression
EXP
Cephaloridine results in increased expression of FOXQ1 mRNA
CTD
PMID:18500788
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
EXP
Cephaloridine results in decreased expression of FYCO1 mRNA
CTD
PMID:18500788
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Cephaloridine results in decreased expression of G6PC1 mRNA
CTD
PMID:18500788
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
EXP
Cephaloridine results in increased expression of G6PD mRNA
CTD
PMID:18500788
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP
Cephaloridine results in increased expression of GADD45A mRNA
CTD
PMID:18172885
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Galnt13
polypeptide N-acetylgalactosaminyltransferase 13
increases expression
EXP
Cephaloridine results in increased expression of GALNT13 mRNA
CTD
PMID:18500788
NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
G
Ganc
glucosidase, alpha; neutral C
decreases expression
EXP
Cephaloridine results in decreased expression of GANC mRNA
CTD
PMID:18500788
NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241
G
Garin4
golgi associated RAB2 interactor family member 4
increases expression
EXP
Cephaloridine results in increased expression of GARIN4 mRNA
CTD
PMID:18500788
NCBI chr13:102,742,988...102,745,168
Ensembl chr13:102,742,988...102,745,168
G
Gba3
glucosylceramidase beta 3
decreases expression
EXP
Cephaloridine results in decreased expression of GBA3 mRNA
CTD
PMID:18500788
NCBI chr14:60,574,974...60,721,411
Ensembl chr14:60,574,976...60,721,653
G
Gda
guanine deaminase
increases expression
EXP
Cephaloridine results in increased expression of GDA mRNA
CTD
PMID:18500788
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Gdf15
growth differentiation factor 15
decreases expression
EXP
Cephaloridine results in decreased expression of GDF15 mRNA
CTD
PMID:18500788
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gfra2
GDNF family receptor alpha 2
decreases expression
EXP
Cephaloridine results in decreased expression of GFRA2 mRNA
CTD
PMID:18500788
NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714
G
Gins2
GINS complex subunit 2
increases expression
EXP
Cephaloridine results in increased expression of GINS2 mRNA
CTD
PMID:18500788
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gins4
GINS complex subunit 4
increases expression
EXP
Cephaloridine results in increased expression of GINS4 mRNA
CTD
PMID:18500788
NCBI chr16:68,787,572...68,799,938
Ensembl chr16:68,767,339...68,802,273
G
Gmnn
geminin, DNA replication inhibitor
increases expression
EXP
Cephaloridine results in increased expression of GMNN mRNA
CTD
PMID:18500788
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
G
Gna14
G protein subunit alpha 14
increases expression
EXP
Cephaloridine results in increased expression of GNA14 mRNA
CTD
PMID:18500788
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
G
Gpnmb
glycoprotein nmb
increases expression
EXP
Cephaloridine results in increased expression of GPNMB mRNA
CTD
PMID:18500788
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr135
G protein-coupled receptor 135
decreases expression
EXP
Cephaloridine results in decreased expression of GPR135 mRNA
CTD
PMID:18500788
NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551
G
Gpr19
G protein-coupled receptor 19
increases expression
EXP
Cephaloridine results in increased expression of GPR19 mRNA
CTD
PMID:18500788
NCBI chr 4:167,710,944...167,739,232
Ensembl chr 4:167,710,666...167,741,036
G
Gpx2
glutathione peroxidase 2
increases expression
EXP
Cephaloridine results in increased expression of GPX2 mRNA
CTD
PMID:18500788
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
decreases expression
EXP
Cephaloridine results in decreased expression of GRIA3 mRNA
CTD
PMID:18500788
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
G
Gsr
glutathione-disulfide reductase
increases expression
EXP
Cephaloridine results in increased expression of GSR mRNA
CTD
PMID:18172885
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta2
glutathione S-transferase alpha 2
increases expression
EXP
Cephaloridine results in increased expression of GSTA2 mRNA
CTD
PMID:18172885
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta5
glutathione S-transferase alpha 5
increases expression
EXP
Cephaloridine results in increased expression of GSTA5 mRNA
CTD
PMID:18172885
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP
Cephaloridine results in increased expression of GSTM1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
Cephaloridine results in increased expression of GSTP1 mRNA
CTD
PMID:18500788
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gxylt1
glucoside xylosyltransferase 1
decreases expression
EXP
Cephaloridine results in decreased expression of GXYLT1 mRNA
CTD
PMID:18500788
NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699
G
H1f1
H1.1 linker histone, cluster member
increases expression
EXP
Cephaloridine results in increased expression of H1F1 mRNA
CTD
PMID:18500788
NCBI chr17:41,366,268...41,367,011
Ensembl chr17:41,366,268...41,367,011
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
EXP
Cephaloridine results in decreased expression of HADH mRNA
CTD
PMID:18500788
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Haus8
HAUS augmin-like complex, subunit 8
increases expression
EXP
Cephaloridine results in increased expression of HAUS8 mRNA
CTD
PMID:18500788
NCBI chr16:17,930,819...17,945,254
Ensembl chr16:17,930,820...17,945,237
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression
EXP
Cephaloridine results in increased expression of HAVCR1 mRNA
CTD
PMID:18500788 PMID:20305092
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
increases expression
EXP
Cephaloridine results in increased expression of HCK mRNA
CTD
PMID:18500788
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
G
Hebp1
heme binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of HEBP1 mRNA
CTD
PMID:18500788
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
G
Hebp2
heme binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of HEBP2 mRNA
CTD
PMID:18500788
NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777
G
Hells
helicase, lymphoid specific
increases expression
EXP
Cephaloridine results in increased expression of HELLS mRNA
CTD
PMID:18500788
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Hepacam2
HEPACAM family member 2
increases expression
EXP
Cephaloridine results in increased expression of HEPACAM2 mRNA
CTD
PMID:18500788
NCBI chr 4:31,446,195...31,480,859
Ensembl chr 4:31,446,169...31,480,953
G
Hjv
hemojuvelin BMP co-receptor
decreases expression
EXP
Cephaloridine results in decreased expression of HJV mRNA
CTD
PMID:18500788
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
G
Hlx
H2.0-like homeobox
decreases expression
EXP
Cephaloridine results in decreased expression of HLX mRNA
CTD
PMID:18500788
NCBI chr13:96,280,335...96,285,750
Ensembl chr13:96,280,339...96,285,750
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
Cephaloridine results in decreased expression of HMGCS2 mRNA
CTD
PMID:18500788
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
increases expression
EXP
Cephaloridine results in increased expression of HMOX1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmx3
H6 family homeobox 3
increases expression
EXP
Cephaloridine results in increased expression of HMX3 mRNA
CTD
PMID:18500788
NCBI chr 1:186,313,237...186,315,201
Ensembl chr 1:186,313,063...186,315,201
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
EXP
Cephaloridine results in increased expression of HNRNPA1 mRNA
CTD
PMID:18500788
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpa1-ps28
heterogeneous nuclear ribonucleoprotein A1, pseudogene 28
increases expression
EXP
Cephaloridine results in increased expression of HNRNPA1-PS28 mRNA
CTD
PMID:18500788
NCBI chr X:107,752,105...107,759,183
G
Hrg
histidine-rich glycoprotein
decreases expression
EXP
Cephaloridine results in decreased expression of HRG mRNA
CTD
PMID:18500788
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
Cephaloridine results in decreased expression of HSD17B2 mRNA
CTD
PMID:18500788
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
increases expression
EXP
Cephaloridine results in increased expression of HSD3B1 mRNA
CTD
PMID:18500788
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
Cephaloridine results in increased expression of HSP90AA1 mRNA
CTD
PMID:18500788
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
EXP
Cephaloridine results in increased expression of HSPA1A mRNA
CTD
PMID:18500788
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
Cephaloridine results in increased expression of HSPA1B mRNA
CTD
PMID:18500788
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
Cephaloridine results in increased expression of HSPH1 mRNA
CTD
PMID:18500788
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
EXP
Cephaloridine results in increased expression of HTATIP2 mRNA
CTD
PMID:18500788
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
increases expression
EXP
Cephaloridine results in increased expression of HTR5B mRNA
CTD
PMID:18500788
NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835
G
Icam1
intercellular adhesion molecule 1
increases expression
EXP
Cephaloridine results in increased expression of ICAM1 mRNA
CTD
PMID:18500788
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Idi2l3
isopentenyl-diphosphate delta isomerase 2 like 3
decreases expression
EXP
Cephaloridine results in decreased expression of IDI2L3 mRNA
CTD
PMID:18500788
NCBI chr17:61,518,138...61,535,484
Ensembl chr17:61,519,390...61,531,603
G
Ier3
immediate early response 3
decreases expression
EXP
Cephaloridine results in decreased expression of IER3 mRNA
CTD
PMID:18500788
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifitm10
interferon induced transmembrane protein 10
increases expression
EXP
Cephaloridine results in increased expression of IFITM10 mRNA
CTD
PMID:18500788
NCBI chr 1:197,507,501...197,524,180
Ensembl chr 1:197,507,503...197,525,151
G
Il18
interleukin 18
increases expression
EXP
Cephaloridine results in increased expression of IL18 mRNA
CTD
PMID:18500788
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
decreases expression
EXP
Cephaloridine results in decreased expression of IL1B mRNA
CTD
PMID:18500788
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il20ra
interleukin 20 receptor subunit alpha
decreases expression
EXP
Cephaloridine results in decreased expression of IL20RA mRNA
CTD
PMID:18500788
NCBI chr 1:14,424,215...14,494,226
Ensembl chr 1:14,451,228...14,493,602
G
Inhbb
inhibin subunit beta B
decreases expression
EXP
Cephaloridine results in decreased expression of INHBB mRNA
CTD
PMID:18500788
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Itpka
inositol-trisphosphate 3-kinase A
increases expression
EXP
Cephaloridine results in increased expression of ITPKA mRNA
CTD
PMID:18500788
NCBI chr 3:106,726,036...106,734,601
Ensembl chr 3:106,726,036...106,734,600
G
Itpkb
inositol-trisphosphate 3-kinase B
increases expression
EXP
Cephaloridine results in increased expression of ITPKB mRNA
CTD
PMID:18500788
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
G
Jade2
jade family PHD finger 2
decreases expression
EXP
Cephaloridine results in decreased expression of JADE2 mRNA
CTD
PMID:18500788
NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Cephaloridine results in increased expression of JUN mRNA
CTD
PMID:18172885
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
EXP
Cephaloridine results in decreased expression of JUNB mRNA Cephaloridine results in increased expression of JUNB mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kbtbd11
kelch repeat and BTB domain containing 11
decreases expression
EXP
Cephaloridine results in decreased expression of KBTBD11 mRNA
CTD
PMID:18500788
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
G
Kcnh1
potassium voltage-gated channel subfamily H member 1
increases expression
EXP
Cephaloridine results in increased expression of KCNH1 mRNA
CTD
PMID:18500788
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
G
Kcnj15
potassium inwardly-rectifying channel, subfamily J, member 15
decreases expression
EXP
Cephaloridine results in decreased expression of KCNJ15 mRNA
CTD
PMID:18500788
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
G
Kctd1
potassium channel tetramerization domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of KCTD1 mRNA
CTD
PMID:18500788
NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393
G
Kgd4
alpha-ketoglutarate dehydrogenase subunit 4
increases expression
EXP
Cephaloridine results in increased expression of KGD4 mRNA
CTD
PMID:18500788
NCBI chr 2:31,870,549...31,878,335
Ensembl chr 2:31,870,551...31,880,730
G
Kif18a
kinesin family member 18A
decreases expression
EXP
Cephaloridine results in decreased expression of KIF18A mRNA
CTD
PMID:18500788
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
G
Kif2c
kinesin family member 2C
decreases expression
EXP
Cephaloridine results in decreased expression of KIF2C mRNA
CTD
PMID:18500788
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Klf7
KLF transcription factor 7
decreases expression
EXP
Cephaloridine results in decreased expression of KLF7 mRNA
CTD
PMID:18500788
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
G
Klhl25
kelch-like family member 25
decreases expression
EXP
Cephaloridine results in decreased expression of KLHL25 mRNA
CTD
PMID:18500788
NCBI chr 1:129,724,894...129,750,142
Ensembl chr 1:129,722,026...129,750,227
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of KNSTRN mRNA
CTD
PMID:18500788
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Kntc1
kinetochore associated 1
increases expression
EXP
Cephaloridine results in increased expression of KNTC1 mRNA
CTD
PMID:18500788
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
G
Lama2
laminin subunit alpha 2
decreases expression
EXP
Cephaloridine results in decreased expression of LAMA2 mRNA
CTD
PMID:18500788
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
G
Lamb3
laminin subunit beta 3
increases expression
EXP
Cephaloridine results in increased expression of LAMB3 mRNA
CTD
PMID:18500788
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lars1
leucyl-tRNA synthetase 1
decreases expression
EXP
Cephaloridine results in decreased expression of LARS1 mRNA
CTD
PMID:18500788
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
G
Lcor
ligand dependent nuclear receptor corepressor
decreases expression
EXP
Cephaloridine results in decreased expression of LCOR mRNA
CTD
PMID:18500788
NCBI chr 1:240,298,565...240,405,627
Ensembl chr 1:240,298,563...240,402,448
G
Lect2
leukocyte cell-derived chemotaxin 2
decreases expression
EXP
Cephaloridine results in decreased expression of LECT2 mRNA
CTD
PMID:18500788
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
G
Lgals2
galectin 2
increases expression
EXP
Cephaloridine results in increased expression of LGALS2 mRNA
CTD
PMID:18500788
NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802
G
Lgals3
galectin 3
increases expression
EXP
Cephaloridine results in increased expression of LGALS3 mRNA
CTD
PMID:18500788
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lhx3
LIM homeobox 3
decreases expression
EXP
Cephaloridine results in decreased expression of LHX3 mRNA
CTD
PMID:18500788
NCBI chr 3:9,026,432...9,035,122
Ensembl chr 3:9,027,425...9,034,480
G
Lig1
DNA ligase 1
increases expression
EXP
Cephaloridine results in increased expression of LIG1 mRNA
CTD
PMID:18500788
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lmnb1
lamin B1
decreases expression
EXP
Cephaloridine results in decreased expression of LMNB1 mRNA
CTD
PMID:18500788
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lratd1
LRAT domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of LRATD1 mRNA
CTD
PMID:18500788
NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319
G
Lrrn3
leucine rich repeat neuronal 3
decreases expression
EXP
Cephaloridine results in decreased expression of LRRN3 mRNA
CTD
PMID:18500788
NCBI chr 6:58,489,060...58,520,322
Ensembl chr 6:58,489,010...58,520,330
G
Maf
MAF bZIP transcription factor
decreases expression
EXP
Cephaloridine results in decreased expression of MAF mRNA
CTD
PMID:18500788
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
increases expression
EXP
Cephaloridine results in increased expression of MAP3K1 mRNA
CTD
PMID:18172885
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k12
mitogen activated protein kinase kinase kinase 12
decreases expression
EXP
Cephaloridine results in decreased expression of MAP3K12 mRNA
CTD
PMID:18172885
NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:133,630,835...133,640,789
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation increases activity
EXP
Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK1 protein] Cephaloridine results in increased activity of MAPK1 protein
CTD
PMID:16154539 PMID:16272694
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases activity multiple interactions increases phosphorylation
EXP
Cephaloridine results in increased activity of MAPK3 protein Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK3 protein]
CTD
PMID:16154539 PMID:16272694
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
EXP
Cephaloridine results in increased expression of MAPK8IP3 mRNA
CTD
PMID:18500788
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
G
Masp2
MBL associated serine protease 2
increases expression
EXP
Cephaloridine results in increased expression of MASP2 mRNA
CTD
PMID:18500788
NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580
G
Mcm2
minichromosome maintenance complex component 2
increases expression
EXP
Cephaloridine results in increased expression of MCM2 mRNA
CTD
PMID:18500788
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
increases expression
EXP
Cephaloridine results in increased expression of MCM3 mRNA
CTD
PMID:18500788
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm5
minichromosome maintenance complex component 5
increases expression
EXP
Cephaloridine results in increased expression of MCM5 mRNA
CTD
PMID:18500788
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
increases expression
EXP
Cephaloridine results in increased expression of MCM6 mRNA
CTD
PMID:18500788
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Mcm7
minichromosome maintenance complex component 7
increases expression
EXP
Cephaloridine results in increased expression of MCM7 mRNA
CTD
PMID:18500788
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mcm8
minichromosome maintenance 8 homologous recombination repair factor
increases expression
EXP
Cephaloridine results in increased expression of MCM8 mRNA
CTD
PMID:18500788
NCBI chr 3:120,086,741...120,117,008
Ensembl chr 3:120,086,763...120,117,008
G
Mesp1
mesoderm posterior bHLH transcription factor 1
decreases expression
EXP
Cephaloridine results in decreased expression of MESP1 mRNA
CTD
PMID:18500788
NCBI chr 1:133,738,357...133,739,875
Ensembl chr 1:133,738,357...133,739,875
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
EXP
Cephaloridine results in increased expression of MET mRNA
CTD
PMID:18172885
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mgll
monoglyceride lipase
decreases expression
EXP
Cephaloridine results in decreased expression of MGLL mRNA
CTD
PMID:18500788
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mki67
marker of proliferation Ki-67
decreases expression
EXP
Cephaloridine results in decreased expression of MKI67 mRNA
CTD
PMID:18500788
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp12
matrix metallopeptidase 12
increases expression
EXP
Cephaloridine results in increased expression of MMP12 mRNA
CTD
PMID:18500788
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp16
matrix metallopeptidase 16
increases expression
EXP
Cephaloridine results in increased expression of MMP16 mRNA
CTD
PMID:18500788
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
G
Mnd1
meiotic nuclear divisions 1
increases expression
EXP
Cephaloridine results in increased expression of MND1 mRNA
CTD
PMID:18500788
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mns1
meiosis-specific nuclear structural 1
decreases expression
EXP
Cephaloridine results in decreased expression of MNS1 mRNA
CTD
PMID:18500788
NCBI chr 8:73,148,877...73,169,570
Ensembl chr 8:73,148,877...73,176,925
G
Mpst
mercaptopyruvate sulfurtransferase
decreases expression
EXP
Cephaloridine results in decreased expression of MPST mRNA
CTD
PMID:18500788
NCBI chr 7:109,955,581...109,963,155
Ensembl chr 7:109,955,675...109,963,141
G
Mpv17l
MPV17 mitochondrial inner membrane protein like
decreases expression
EXP
Cephaloridine results in decreased expression of MPV17L mRNA
CTD
PMID:18500788
NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649
G
Mt1
metallothionein 1
decreases expression
EXP
Cephaloridine results in decreased expression of MT1A mRNA
CTD
PMID:18172885
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
increases expression
EXP
Cephaloridine results in increased expression of MTHFD1L mRNA
CTD
PMID:18500788
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
EXP
Cephaloridine results in increased expression of MTHFD2 mRNA
CTD
PMID:18500788
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Myom3
myomesin 3
increases expression
EXP
Cephaloridine results in increased expression of MYOM3 mRNA
CTD
PMID:18500788
NCBI chr 5:147,992,737...148,043,282
Ensembl chr 5:147,992,737...148,043,274
G
Ncor2
nuclear receptor co-repressor 2
decreases expression
EXP
Cephaloridine results in decreased expression of NCOR2 mRNA
CTD
PMID:18500788
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Nek6
NIMA-related kinase 6
increases expression
EXP
Cephaloridine results in increased expression of NEK6 mRNA
CTD
PMID:18500788
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
EXP
Cephaloridine results in increased expression of NFIL3 mRNA
CTD
PMID:18500788
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nfkbia
NFKB inhibitor alpha
decreases expression
EXP
Cephaloridine results in decreased expression of NFKBIA mRNA
CTD
PMID:18172885
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbiz
NFKB inhibitor zeta
decreases expression
EXP
Cephaloridine results in decreased expression of NFKBIZ mRNA
CTD
PMID:18500788
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Ngfr
nerve growth factor receptor
increases expression
EXP
Cephaloridine results in increased expression of NGFR mRNA
CTD
PMID:18500788
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nhp2
NHP2 ribonucleoprotein
increases expression
EXP
Cephaloridine results in increased expression of NHP2 mRNA
CTD
PMID:18500788
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
G
Ninj2
ninjurin 2
increases expression
EXP
Cephaloridine results in increased expression of NINJ2 mRNA
CTD
PMID:18500788
NCBI chr 4:153,306,439...153,408,618
Ensembl chr 4:153,306,553...153,408,617
G
Nipsnap3a
nipsnap homolog 3A (C. elegans)
increases expression
EXP
Cephaloridine results in increased expression of NIPSNAP3B mRNA
CTD
PMID:18500788
NCBI chr 5:67,613,993...67,625,067
Ensembl chr 5:67,614,036...67,669,700
G
Nme4
NME/NM23 nucleoside diphosphate kinase 4
decreases expression
EXP
Cephaloridine results in decreased expression of NME4 mRNA
CTD
PMID:18500788
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
G
Nop56
NOP56 ribonucleoprotein
increases expression
EXP
Cephaloridine results in increased expression of NOP56 mRNA
CTD
PMID:18500788
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Cephaloridine results in increased expression of NQO1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
EXP
Cephaloridine results in increased expression of NR1D1 mRNA
CTD
PMID:18500788
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nrm
nurim
increases expression
EXP
Cephaloridine results in increased expression of NRM mRNA
CTD
PMID:18500788
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802
G
Nudt10
nudix hydrolase 10
increases expression
EXP
Cephaloridine results in increased expression of NUDT10 mRNA
CTD
PMID:18500788
G
Nudt11
nudix hydrolase 11
increases expression
EXP
Cephaloridine results in increased expression of NUDT11 mRNA
CTD
PMID:18500788
NCBI chr X:16,326,775...16,333,396
Ensembl chr X:16,326,598...16,333,145
G
Oprl1
opioid related nociceptin receptor 1
increases expression
EXP
Cephaloridine results in increased expression of OPRL1 mRNA
CTD
PMID:18500788
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
G
Or2w6
olfactory receptor family 2 subfamily W member 6
increases expression
EXP
Cephaloridine results in increased expression of OR2W6 mRNA
CTD
PMID:18500788
NCBI chr17:42,906,458...42,907,396
Ensembl chr17:42,904,951...42,919,599
G
Or52b2
olfactory receptor family 52 subfamily B member 2
increases expression
EXP
Cephaloridine results in increased expression of OR52B2 mRNA
CTD
PMID:18500788
NCBI chr 1:159,695,507...159,696,475
Ensembl chr 1:159,694,964...159,701,227
G
Or52k1
olfactory receptor family 52 subfamily K member 1
decreases expression
EXP
Cephaloridine results in decreased expression of OR52K1 mRNA
CTD
PMID:18500788
NCBI chr 1:157,037,381...157,038,325
Ensembl chr 1:157,037,381...157,038,325
G
Orc6
origin recognition complex, subunit 6
increases expression
EXP
Cephaloridine results in increased expression of ORC6 mRNA
CTD
PMID:18500788
NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662
G
Osbpl8
oxysterol binding protein-like 8
decreases expression
EXP
Cephaloridine results in decreased expression of OSBPL8 mRNA
CTD
PMID:18500788
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
G
Osmr
oncostatin M receptor
increases expression
EXP
Cephaloridine results in increased expression of OSMR mRNA
CTD
PMID:18500788
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
G
Oxgr1
oxoglutarate receptor 1
increases expression
EXP
Cephaloridine results in increased expression of OXGR1 mRNA
CTD
PMID:18500788
NCBI chr15:97,145,947...97,146,960
Ensembl chr15:97,144,293...97,166,612
G
Padi6
peptidyl arginine deiminase 6
increases expression
EXP
Cephaloridine results in increased expression of PADI6 mRNA
CTD
PMID:18500788
NCBI chr 5:153,021,855...153,037,443
Ensembl chr 5:153,021,965...153,037,414
G
Palb2
partner and localizer of BRCA2
increases expression
EXP
Cephaloridine results in increased expression of PALB2 mRNA
CTD
PMID:18500788
NCBI chr 1:176,665,076...176,689,053
Ensembl chr 1:176,665,076...176,688,990
G
Pask
PAS domain containing serine/threonine kinase
increases expression
EXP
Cephaloridine results in increased expression of PASK mRNA
CTD
PMID:18500788
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pbk
PDZ binding kinase
decreases expression
EXP
Cephaloridine results in decreased expression of PBK mRNA
CTD
PMID:18500788
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pcdh7
protocadherin 7
decreases expression
EXP
Cephaloridine results in decreased expression of PCDH7 mRNA
CTD
PMID:18500788
NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051 Ensembl chr14:52,475,610...52,902,051
G
Pcdh9
protocadherin 9
decreases expression
EXP
Cephaloridine results in decreased expression of PCDH9 mRNA
CTD
PMID:18500788
NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of PCK1 mRNA
CTD
PMID:18500788
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pclaf
PCNA clamp associated factor
increases expression
EXP
Cephaloridine results in increased expression of PCLAF mRNA
CTD
PMID:18500788
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcna
proliferating cell nuclear antigen
increases expression
EXP
Cephaloridine results in increased expression of PCNA mRNA
CTD
PMID:18500788
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
EXP
Cephaloridine results in increased expression of PDIA4 mRNA
CTD
PMID:18172885
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pfn3
profilin 3
decreases expression
EXP
Cephaloridine results in decreased expression of PFN3 mRNA
CTD
PMID:18500788
NCBI chr17:9,217,595...9,218,122
G
Pipox
pipecolic acid and sarcosine oxidase
increases expression
EXP
Cephaloridine results in increased expression of PIPOX mRNA
CTD
PMID:18500788
NCBI chr10:62,769,874...62,783,484
Ensembl chr10:62,769,900...62,782,370
G
Pir
pirin
increases expression
EXP
Cephaloridine results in increased expression of PIR mRNA
CTD
PMID:18500788
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pkhd1
PKHD1 ciliary IPT domain containing fibrocystin/polyductin
decreases expression
EXP
Cephaloridine results in decreased expression of PKHD1 mRNA
CTD
PMID:18500788
NCBI chr 9:22,547,396...23,037,443
Ensembl chr 9:22,549,513...23,037,381
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
increases expression
EXP
Cephaloridine results in increased expression of PKMYT1 mRNA
CTD
PMID:18500788
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
G
Pla1a
phospholipase A1 member A
increases expression
EXP
Cephaloridine results in increased expression of PLA1A mRNA
CTD
PMID:18500788
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
G
Plek2
pleckstrin 2
increases expression
EXP
Cephaloridine results in increased expression of PLEK2 mRNA
CTD
PMID:18500788
NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326
G
Plekha5
pleckstrin homology domain containing A5
decreases expression
EXP
Cephaloridine results in decreased expression of PLEKHA5 mRNA
CTD
PMID:18500788
NCBI chr 4:173,333,891...173,503,546
Ensembl chr 4:173,334,055...173,503,546
G
Plk1
polo-like kinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of PLK1 mRNA
CTD
PMID:18500788
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Pola2
DNA polymerase alpha 2, accessory subunit
increases expression
EXP
Cephaloridine results in increased expression of POLA2 mRNA
CTD
PMID:18500788
NCBI chr 1:203,227,183...203,251,350
Ensembl chr 1:203,203,388...203,251,348
G
Pold1
DNA polymerase delta 1, catalytic subunit
increases expression
EXP
Cephaloridine results in increased expression of POLD1 mRNA
CTD
PMID:18500788
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Pole
DNA polymerase epsilon, catalytic subunit
increases expression
EXP
Cephaloridine results in increased expression of POLE mRNA
CTD
PMID:18500788
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939
G
Ppa1
inorganic pyrophosphatase 1
increases expression
EXP
Cephaloridine results in increased expression of PPA1 mRNA
CTD
PMID:18500788
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Ppm1j
protein phosphatase, Mg2+/Mn2+ dependent, 1J
increases expression
EXP
Cephaloridine results in increased expression of PPM1J mRNA
CTD
PMID:18500788
NCBI chr 2:192,278,597...192,283,883
Ensembl chr 2:192,278,517...192,283,882
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
EXP
Cephaloridine results in decreased expression of PPP1R15A mRNA
CTD
PMID:18500788
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prc1
protein regulator of cytokinesis 1
decreases expression
EXP
Cephaloridine results in decreased expression of PRC1 mRNA
CTD
PMID:18500788
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prim1
DNA primase subunit 1
increases expression
EXP
Cephaloridine results in increased expression of PRIM1 mRNA
CTD
PMID:18500788
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
increases expression
EXP
Cephaloridine results in increased expression of PRKAR1B mRNA
CTD
PMID:18500788
NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942
G
Prodh2
proline dehydrogenase 2
decreases expression
EXP
Cephaloridine results in decreased expression of PRODH2 mRNA
CTD
PMID:18500788
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
G
Prrx1
paired related homeobox 1
decreases expression
EXP
Cephaloridine results in decreased expression of PRRX1 mRNA
CTD
PMID:18500788
NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866
G
Prss35
serine protease 35
decreases expression
EXP
Cephaloridine results in decreased expression of PRSS35 mRNA
CTD
PMID:18500788
NCBI chr 8:87,714,449...87,731,009
Ensembl chr 8:87,714,966...87,731,009
G
Psmb4
proteasome 20S subunit beta 4
increases expression
EXP
Cephaloridine results in increased expression of PSMB4 mRNA
CTD
PMID:18172885
NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746
G
Ptbp1
polypyrimidine tract binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of PTBP1 mRNA
CTD
PMID:18172885
NCBI chr 7:9,842,574...9,852,332
Ensembl chr 7:9,842,574...9,852,397
G
Ptgr1
prostaglandin reductase 1
increases expression
EXP
Cephaloridine results in increased expression of PTGR1 mRNA
CTD
PMID:18500788
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
decreases expression
EXP
Cephaloridine results in decreased expression of PTPN11 mRNA
CTD
PMID:18500788
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptprb
protein tyrosine phosphatase, receptor type, B
decreases expression
EXP
Cephaloridine results in decreased expression of PTPRB mRNA
CTD
PMID:18500788
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
G
Ptprn2
protein tyrosine phosphatase, receptor type N2
increases expression
EXP
Cephaloridine results in increased expression of PTPRN2 mRNA
CTD
PMID:18500788
NCBI chr 6:137,439,572...138,191,575
Ensembl chr 6:137,439,540...138,191,575
G
Ptrh1
peptidyl-tRNA hydrolase 1 homolog
increases expression
EXP
Cephaloridine results in increased expression of PTRH1 mRNA
CTD
PMID:18500788
NCBI chr 3:16,064,867...16,071,098
Ensembl chr 3:16,064,880...16,070,648
G
Pvr
PVR cell adhesion molecule
increases expression
EXP
Cephaloridine results in increased expression of PVR mRNA
CTD
PMID:18500788
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Rab11fip3
RAB11 family interacting protein 3
decreases expression
EXP
Cephaloridine results in decreased expression of RAB11FIP3 mRNA
CTD
PMID:18500788
NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479
G
Rab31
RAB31, member RAS oncogene family
decreases expression
EXP
Cephaloridine results in decreased expression of RAB31 mRNA
CTD
PMID:18500788
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
G
Rad18
RAD18 E3 ubiquitin protein ligase
increases expression
EXP
Cephaloridine results in increased expression of RAD18 mRNA
CTD
PMID:18500788
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
G
Rb1
RB transcriptional corepressor 1
affects activity
EXP
Cephaloridine affects the activity of RB1 protein
CTD
PMID:18500788
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbp2
retinol binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of RBP2 mRNA
CTD
PMID:18500788
NCBI chr 8:99,079,293...99,104,489
Ensembl chr 8:99,079,104...99,104,473
G
Rbsn
rabenosyn, RAB effector
decreases expression
EXP
Cephaloridine results in decreased expression of RBSN mRNA
CTD
PMID:18500788
NCBI chr 4:124,682,228...124,712,578
Ensembl chr 4:124,683,969...124,712,578
G
Rdh16
retinol dehydrogenase 16
decreases expression
EXP
Cephaloridine results in decreased expression of RDH2 mRNA
CTD
PMID:18500788
NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124
G
Recql4
RecQ like helicase 4
increases expression
EXP
Cephaloridine results in increased expression of RECQL4 mRNA
CTD
PMID:18500788
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
G
Rela
RELA proto-oncogene, NF-kB subunit
affects activity
EXP
Cephaloridine affects the activity of RELA protein
CTD
PMID:18500788
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rfc3
replication factor C subunit 3
increases expression
EXP
Cephaloridine results in increased expression of RFC3 mRNA
CTD
PMID:18500788
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
G
Rfc4
replication factor C subunit 4
increases expression
EXP
Cephaloridine results in increased expression of RFC4 mRNA
CTD
PMID:18500788
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
G
Rgn
regucalcin
decreases expression
EXP
Cephaloridine results in decreased expression of RGN mRNA
CTD
PMID:8584014 PMID:18500788
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rgs11
regulator of G-protein signaling 11
increases expression
EXP
Cephaloridine results in increased expression of RGS11 mRNA
CTD
PMID:18500788
NCBI chr10:15,222,804...15,231,062
Ensembl chr10:15,222,803...15,231,060
G
Rhcg
Rh family, C glycoprotein
increases expression
EXP
Cephaloridine results in increased expression of RHCG mRNA
CTD
PMID:18500788
NCBI chr 1:133,531,704...133,555,902
Ensembl chr 1:133,531,716...133,555,876
G
Rhobtb1
Rho-related BTB domain containing 1
decreases expression
EXP
Cephaloridine results in decreased expression of RHOBTB1 mRNA
CTD
PMID:18500788
NCBI chr20:19,327,142...19,456,121
Ensembl chr20:19,327,155...19,403,012
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of RHPN2 mRNA
CTD
PMID:18500788
NCBI chr 1:87,991,143...88,051,895
Ensembl chr 1:87,991,144...88,051,902
G
Rida
reactive intermediate imine deaminase A homolog
decreases expression
EXP
Cephaloridine results in decreased expression of RIDA mRNA
CTD
PMID:18500788
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
G
Rnd1
Rho family GTPase 1
increases expression
EXP
Cephaloridine results in increased expression of RND1 mRNA
CTD
PMID:18500788
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnf227
ring finger protein 227
increases expression
EXP
Cephaloridine results in increased expression of RNF227 mRNA
CTD
PMID:18500788
NCBI chr10:54,061,054...54,063,015
Ensembl chr10:54,059,947...54,063,010
G
Rpl23a
ribosomal protein L23A
increases expression
EXP
Cephaloridine results in increased expression of RPL23A mRNA
CTD
PMID:18500788
NCBI chr10:63,076,660...63,079,346
Ensembl chr10:63,076,066...63,079,346
G
Rpl23al1
ribosomal protein L23A like 1
increases expression
EXP
Cephaloridine results in increased expression of RPL23AL1 mRNA
CTD
PMID:18500788
NCBI chr 2:38,452,814...38,453,384
Ensembl chr 2:38,451,401...38,453,417
G
Rpl32l4
ribosomal protein L32 like 4
decreases expression
EXP
Cephaloridine results in decreased expression of RPL32L4 mRNA
CTD
PMID:18500788
NCBI chr 8:84,691,128...84,692,042
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
Cephaloridine results in decreased expression of RRM2 mRNA
CTD
PMID:18500788
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
decreases expression
EXP
Cephaloridine results in decreased expression of RUNX1T1 mRNA
CTD
PMID:18500788
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
G
Rxrg
retinoid X receptor gamma
increases expression
EXP
Cephaloridine results in increased expression of RXRG mRNA
CTD
PMID:18500788
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
Scgb3a1
secretoglobin, family 3A, member 1
increases expression
EXP
Cephaloridine results in increased expression of SCGB3A1 mRNA
CTD
PMID:18500788
NCBI chr10:33,968,059...33,969,366
Ensembl chr10:33,968,059...33,969,476
G
Scgb3a2
secretoglobin, family 3A, member 2
increases expression
EXP
Cephaloridine results in increased expression of SCGB3A2 mRNA
CTD
PMID:18500788
NCBI chr18:35,932,840...35,935,762
Ensembl chr18:35,932,840...35,935,762
G
Sct
secretin
increases expression
EXP
Cephaloridine results in increased expression of SCT mRNA
CTD
PMID:18500788
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
G
Sectm1b
secreted and transmembrane 1B
increases expression
EXP
Cephaloridine results in increased expression of SECTM1A mRNA
CTD
PMID:18500788
NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769
G
Selenop
selenoprotein P
decreases expression
EXP
Cephaloridine results in decreased expression of SELENOP mRNA
CTD
PMID:18500788
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sema4c
semaphorin 4C
decreases expression
EXP
Cephaloridine results in decreased expression of SEMA4C mRNA
CTD
PMID:18500788
NCBI chr 9:38,791,668...38,802,171
Ensembl chr 9:38,791,670...38,802,128
G
Septin10
septin 10
decreases expression
EXP
Cephaloridine results in decreased expression of SEPTIN10 mRNA
CTD
PMID:18500788
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
G
Sh2b2
SH2B adaptor protein 2
increases expression
EXP
Cephaloridine results in increased expression of SH2B2 mRNA
CTD
PMID:18500788
NCBI chr12:20,427,057...20,456,845
Ensembl chr12:20,429,043...20,456,844
G
Sh3bp2
SH3-domain binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of SH3BP2 mRNA
CTD
PMID:18500788
NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251
G
Shroom4
shroom family member 4
decreases expression
EXP
Cephaloridine results in decreased expression of SHROOM4 mRNA
CTD
PMID:18500788
NCBI chr X:15,869,065...16,076,850
Ensembl chr X:15,869,065...16,076,869
G
Siglec5
sialic acid binding Ig-like lectin 5
increases expression
EXP
Cephaloridine results in increased expression of SIGLEC5 mRNA
CTD
PMID:18500788
NCBI chr 1:93,768,190...93,776,696
Ensembl chr 1:93,768,319...93,776,694
G
Ska1
spindle and kinetochore associated complex subunit 1
decreases expression
EXP
Cephaloridine results in decreased expression of SKA1 mRNA
CTD
PMID:18500788
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
G
Slc15a3
solute carrier family 15 member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC15A3 mRNA
CTD
PMID:18500788
NCBI chr 1:207,492,365...207,507,158
Ensembl chr 1:207,492,365...207,507,157
G
Slc16a12
solute carrier family 16, member 12
decreases expression
EXP
Cephaloridine results in decreased expression of SLC16A12 mRNA
CTD
PMID:18500788
NCBI chr 1:232,184,004...232,262,170
Ensembl chr 1:232,185,907...232,262,141
G
Slc16a14
solute carrier family 16, member 14
decreases expression
EXP
Cephaloridine results in decreased expression of SLC16A14 mRNA
CTD
PMID:18500788
NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
G
Slc1a5
solute carrier family 1 member 5
increases expression
EXP
Cephaloridine results in increased expression of SLC1A5 mRNA
CTD
PMID:18500788
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a23
solute carrier family 22, member 23
decreases expression
EXP
Cephaloridine results in decreased expression of SLC22A23 mRNA
CTD
PMID:18500788
NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
G
Slc22a5
solute carrier family 22 member 5
decreases expression
EXP
Cephaloridine results in decreased expression of SLC22A5 mRNA
CTD
PMID:18500788
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc22a6
solute carrier family 22 member 6
increases import multiple interactions increases uptake
EXP ISO
SLC22A6 protein results in increased import of Cephaloridine Cephaloridine inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of Cephaloridine
CTD
PMID:10594788 PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Cephaloridine Cephaloridine inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc35d2
solute carrier family 35 member D2
increases expression
EXP
Cephaloridine results in increased expression of SLC35D2 mRNA
CTD
PMID:18500788
NCBI chr17:987,899...1,019,747
Ensembl chr17:988,157...1,019,743
G
Slc39a4
solute carrier family 39 member 4
increases expression
EXP
Cephaloridine results in increased expression of SLC39A4 mRNA
CTD
PMID:18500788
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc41a2
solute carrier family 41 member 2
increases expression
EXP
Cephaloridine results in increased expression of SLC41A2 mRNA
CTD
PMID:18500788
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
G
Slc46a3
solute carrier family 46, member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC46A3 mRNA
CTD
PMID:18500788
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
G
Slc4a4
solute carrier family 4 member 4
decreases expression
EXP
Cephaloridine results in decreased expression of SLC4A4 mRNA
CTD
PMID:18500788
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc5a3
solute carrier family 5 member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC5A3 mRNA
CTD
PMID:18500788
NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883
G
Slc7a10
solute carrier family 7 member 10
increases expression
EXP
Cephaloridine results in increased expression of SLC7A10 mRNA
CTD
PMID:18500788
NCBI chr 1:87,829,084...87,845,073
Ensembl chr 1:87,829,175...87,845,071
G
Slc7a5
solute carrier family 7 member 5
increases expression
EXP
Cephaloridine results in increased expression of SLC7A5 mRNA
CTD
PMID:18500788
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slc7a7
solute carrier family 7 member 7
decreases expression
EXP
Cephaloridine results in decreased expression of SLC7A7 mRNA
CTD
PMID:18500788
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Slc8a1
solute carrier family 8 member A1
decreases expression
EXP
Cephaloridine results in decreased expression of SLC8A1 mRNA
CTD
PMID:18500788
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
EXP
Cephaloridine results in increased expression of SLPI mRNA
CTD
PMID:18500788
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Smyd1
SET and MYND domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of SMYD1 mRNA
CTD
PMID:18500788
NCBI chr 4:103,195,330...103,252,989
Ensembl chr 4:103,200,322...103,311,766
G
Snapc2
small nuclear RNA activating complex, polypeptide 2
increases expression
EXP
Cephaloridine results in increased expression of SNAPC2 mRNA
CTD
PMID:18500788
NCBI chr12:2,605,794...2,608,997
Ensembl chr12:2,605,810...2,608,999
G
Socs3
suppressor of cytokine signaling 3
decreases expression
EXP
Cephaloridine results in decreased expression of SOCS3 mRNA
CTD
PMID:18500788
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Spetex2b
Spetex-2B protein
increases expression
EXP
Cephaloridine results in increased expression of SPETEX2B mRNA
CTD
PMID:18500788
G
Spetex2d
Spetex-2D protein
increases expression
EXP
Cephaloridine results in increased expression of SPETEX2D mRNA
CTD
PMID:18500788
G
Sphk1
sphingosine kinase 1
increases expression
EXP
Cephaloridine results in increased expression of SPHK1 mRNA
CTD
PMID:18500788
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Spink1
serine peptidase inhibitor, Kazal type 1
decreases expression
EXP
Cephaloridine results in decreased expression of SPINK1 mRNA
CTD
PMID:18500788
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Srpra
SRP receptor subunit alpha
decreases expression
EXP
Cephaloridine results in decreased expression of SRPRA mRNA
CTD
PMID:18500788
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
Cephaloridine results in increased expression of STAT3 mRNA
CTD
PMID:18500788
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stk35
serine/threonine kinase 35
increases expression
EXP
Cephaloridine results in increased expression of STK35 mRNA
CTD
PMID:18500788
NCBI chr 3:117,016,819...117,049,131
Ensembl chr 3:117,016,950...117,048,066
G
Stra6
signaling receptor and transporter of retinol STRA6
decreases expression
EXP
Cephaloridine results in decreased expression of STRA6 mRNA
CTD
PMID:18500788
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
G
Sult1c2a
sulfotransferase family 1C member 2A
decreases expression
EXP
Cephaloridine results in decreased expression of SULT1C2 mRNA; Cephaloridine results in decreased expression of SULT1C2A mRNA
CTD
PMID:18500788
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
G
Sult4a1
sulfotransferase family 4A, member 1
increases expression
EXP
Cephaloridine results in increased expression of SULT4A1 mRNA
CTD
PMID:18500788
NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085
G
Surf6
surfeit 6
decreases expression
EXP
Cephaloridine results in decreased expression of SURF6 mRNA
CTD
PMID:18500788
NCBI chr 3:10,221,450...10,232,306
Ensembl chr 3:10,221,452...10,232,251
G
Susd2
sushi domain containing 2
decreases expression
EXP
Cephaloridine results in decreased expression of SUSD2 mRNA
CTD
PMID:18500788
NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903
G
Syne1
spectrin repeat containing nuclear envelope protein 1
decreases expression
EXP
Cephaloridine results in decreased expression of SYNE1 mRNA
CTD
PMID:18500788
NCBI chr 1:41,512,146...41,983,382
Ensembl chr 1:41,512,030...41,983,322
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of SYNE2 mRNA
CTD
PMID:18500788
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Sytl5
synaptotagmin-like 5
increases expression
EXP
Cephaloridine results in increased expression of SYTL5 mRNA
CTD
PMID:18500788
NCBI chr X:12,775,529...13,030,134
Ensembl chr X:12,788,698...13,030,175
G
Tac3
tachykinin precursor 3
increases expression
EXP
Cephaloridine results in increased expression of TAC2 mRNA
CTD
PMID:18500788
NCBI chr 7:63,562,552...63,569,170
Ensembl chr 7:63,562,552...63,569,170
G
Tbx3
T-box transcription factor 3
decreases expression
EXP
Cephaloridine results in decreased expression of TBX3 mRNA
CTD
PMID:18500788
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
G
Tcf12
transcription factor 12
decreases expression
EXP
Cephaloridine results in decreased expression of TCF12 mRNA
CTD
PMID:18500788
NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:72,492,567...72,799,201
G
Tcf19
transcription factor 19
increases expression
EXP
Cephaloridine results in increased expression of TCF19 mRNA
CTD
PMID:18500788
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tfrc
transferrin receptor
increases expression
EXP
Cephaloridine results in increased expression of TFRC mRNA
CTD
PMID:18500788
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
increases expression
EXP
Cephaloridine results in increased expression of TICRR mRNA
CTD
PMID:18500788
NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523
G
Timeless
timeless circadian regulator
increases expression
EXP
Cephaloridine results in increased expression of TIMELESS mRNA
CTD
PMID:18500788
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Cephaloridine results in increased expression of TIMP1 mRNA
CTD
PMID:18500788
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tlr2
toll-like receptor 2
increases expression
EXP
Cephaloridine results in increased expression of TLR2 mRNA
CTD
PMID:18500788
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tmem163
transmembrane protein 163
increases expression
EXP
Cephaloridine results in increased expression of TMEM163 mRNA
CTD
PMID:18500788
NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452
G
Tmem252
transmembrane protein 252
decreases expression
EXP
Cephaloridine results in decreased expression of TMEM252 mRNA
CTD
PMID:18500788
NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943
G
Tmem270
transmembrane protein 270
increases expression
EXP
Cephaloridine results in increased expression of TMEM270 mRNA
CTD
PMID:18500788
NCBI chr12:21,793,631...21,798,723
Ensembl chr12:21,794,130...21,798,731
G
Tmem63c
transmembrane protein 63c
increases expression
EXP
Cephaloridine results in increased expression of TMEM63C mRNA
CTD
PMID:18500788
NCBI chr 6:106,667,389...106,738,778
Ensembl chr 6:106,672,934...106,736,990
G
Tmem86a
transmembrane protein 86A
decreases expression
EXP
Cephaloridine results in decreased expression of TMEM86A mRNA
CTD
PMID:18500788
NCBI chr 1:97,595,910...97,600,260
Ensembl chr 1:97,595,842...97,600,260
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
Cephaloridine results in increased expression of TNFRSF12A mRNA
CTD
PMID:18500788
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
EXP
Cephaloridine results in increased expression of TNFRSF1A mRNA
CTD
PMID:18500788
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tns1
tensin 1
decreases expression
EXP
Cephaloridine results in decreased expression of TNS1 mRNA
CTD
PMID:18500788
NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
G
Tns4
tensin 4
increases expression
EXP
Cephaloridine results in increased expression of TNS4 mRNA
CTD
PMID:18500788
NCBI chr10:84,021,965...84,041,346
Ensembl chr10:84,021,966...84,041,346
G
Tonsl
tonsoku-like, DNA repair protein
increases expression
EXP
Cephaloridine results in increased expression of TONSL mRNA
CTD
PMID:18500788
NCBI chr 7:108,345,704...108,360,792
Ensembl chr 7:108,346,047...108,360,750
G
Top2a
DNA topoisomerase II alpha
decreases expression
EXP
Cephaloridine results in decreased expression of TOP2A mRNA
CTD
PMID:18500788
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tph1
tryptophan hydroxylase 1
increases expression
EXP
Cephaloridine results in increased expression of TPH1 mRNA
CTD
PMID:18500788
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
G
Trib3
tribbles pseudokinase 3
increases expression
EXP
Cephaloridine results in increased expression of TRIB3 mRNA
CTD
PMID:18500788
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Tril
TLR4 interactor with leucine-rich repeats
decreases expression
EXP
Cephaloridine results in decreased expression of TRIL mRNA
CTD
PMID:18500788
NCBI chr 4:82,922,327...82,927,172
Ensembl chr 4:82,922,328...82,927,172
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
increases expression
EXP
Cephaloridine results in increased expression of TRPC6 mRNA
CTD
PMID:18500788
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Ttc39a
tetratricopeptide repeat domain 39A
increases expression
EXP
Cephaloridine results in increased expression of TTC39A mRNA
CTD
PMID:18500788
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
G
Ttk
Ttk protein kinase
decreases expression
EXP
Cephaloridine results in decreased expression of TTK mRNA
CTD
PMID:18500788
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
G
Ttll2
tubulin tyrosine ligase like 2
increases expression
EXP
Cephaloridine results in increased expression of TTLL2 mRNA
CTD
PMID:18500788
NCBI chr 1:52,967,183...52,976,690
Ensembl chr 1:52,968,408...52,976,697
G
Tubb3
tubulin, beta 3 class III
increases expression
EXP
Cephaloridine results in increased expression of TUBB3 mRNA
CTD
PMID:18500788
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb6
tubulin, beta 6 class V
increases expression
EXP
Cephaloridine results in increased expression of TUBB6 mRNA
CTD
PMID:18500788
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Tyms
thymidylate synthetase
increases expression
EXP
Cephaloridine results in increased expression of TYMS mRNA
CTD
PMID:18500788
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ubd
ubiquitin D
increases expression
EXP
Cephaloridine results in increased expression of UBD mRNA
CTD
PMID:18500788
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
EXP
Cephaloridine results in decreased expression of UBE2C mRNA
CTD
PMID:18500788
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
increases expression
EXP
Cephaloridine results in increased expression of UBE2L6 mRNA
CTD
PMID:18500788
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ubl7
ubiquitin-like 7
increases expression
EXP
Cephaloridine results in increased expression of UBL7 mRNA
CTD
PMID:18500788
NCBI chr 8:58,321,279...58,340,353
Ensembl chr 8:58,320,866...58,340,344
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
EXP
Cephaloridine results in increased expression of UCHL1 mRNA
CTD
PMID:18500788
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases expression
EXP
Cephaloridine results in increased expression of UGT1A2 mRNA
CTD
PMID:18500788
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
EXP
Cephaloridine results in increased expression of UGT1A6 mRNA
CTD
PMID:18500788
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
increases expression
EXP
Cephaloridine results in increased expression of UGT2B7 mRNA
CTD
PMID:18500788
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Uhmk1
U2AF homology motif kinase 1
increases expression
EXP
Cephaloridine results in increased expression of UHMK1 mRNA
CTD
PMID:18500788
NCBI chr13:82,396,646...82,416,292
Ensembl chr13:82,401,187...82,416,292
G
Uhmk1l1
U2AF homology motif kinase 1l1
increases expression
EXP
Cephaloridine results in increased expression of UHMK1L1 mRNA
CTD
PMID:18500788
NCBI chr17:42,241,640...42,243,666
G
Upp1
uridine phosphorylase 1
increases expression
EXP
Cephaloridine results in increased expression of UPP1 mRNA
CTD
PMID:18500788
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Usp24
ubiquitin specific peptidase 24
decreases expression
EXP
Cephaloridine results in decreased expression of USP24 mRNA
CTD
PMID:18500788
NCBI chr 5:121,080,687...121,210,321
Ensembl chr 5:121,080,470...121,210,311
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Cephaloridine results in increased expression of VCAM1 mRNA
CTD
PMID:18500788
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vpreb3
V-set pre-B cell surrogate light chain 3
increases expression
EXP
Cephaloridine results in increased expression of VPREB3 mRNA
CTD
PMID:18500788
NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of WDHD1 mRNA
CTD
PMID:18500788
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
G
Zc3h13
zinc finger CCCH type containing 13
decreases expression
EXP
Cephaloridine results in decreased expression of ZC3H13 mRNA
CTD
PMID:18500788
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
G
Zdhhc18
zinc finger DHHC-type palmitoyltransferase 18
decreases expression
EXP
Cephaloridine results in decreased expression of ZDHHC18 mRNA
CTD
PMID:18500788
NCBI chr 5:145,821,534...145,859,989
Ensembl chr 5:145,831,446...145,859,993
G
Zfand2a
zinc finger AN1-type containing 2A
decreases expression
EXP
Cephaloridine results in decreased expression of ZFAND2A mRNA
CTD
PMID:18500788
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfp367
zinc finger protein 367
increases expression
EXP
Cephaloridine results in increased expression of ZFP367 mRNA
CTD
PMID:18500788
NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA
CTD
PMID:24657338
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Cephalothin results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Casp3
caspase 3
multiple interactions
ISO
Cephalothin results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:15012731
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Fgf19
fibroblast growth factor 19
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA
CTD
PMID:24657338
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cephalothin binds to and results in decreased activity of SLC25A20 protein; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Slc51b
SLC51 subunit beta
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Tp53
tumor protein p53
increases expression
ISO
Cephalothin results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Vdr
vitamin D receptor
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA
CTD
PMID:24657338
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Cefazolin results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Gsr
glutathione-disulfide reductase
multiple interactions increases expression
ISO
Cefazolin results in increased expression of and results in decreased activity of GSR protein Cefazolin results in increased expression of GSR mRNA
CTD
PMID:32196862
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
RT1-DOa
RT1 class II, locus DOa
affects expression
ISO
Cefazolin affects the expression of HLA-DOA mRNA
CTD
PMID:25811541
NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,753,598...4,756,577
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
affects expression
ISO
Cefazolin affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Slc22a8
solute carrier family 22 member 8
increases uptake
ISO
SLC22A8 protein results in increased uptake of Cefazolin
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cefazolin binds to and results in decreased activity of SLC25A20 protein; Cefazolin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Slc22a6
solute carrier family 22 member 6
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] SLC22A8 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Arhgap45
Rho GTPase activating protein 45
affects expression
ISO
cefepime affects the expression of ARHGAP45 mRNA
CTD
PMID:25811541
NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
G
Cat
catalase
multiple interactions
ISO
cefepime inhibits the reaction [Amikacin results in decreased activity of CAT protein]
CTD
PMID:18781908
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
cefepime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
cefepime results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
RT1-Db1
RT1 class II, locus Db1
affects expression
ISO
cefepime affects the expression of HLA-DRB1 mRNA
CTD
PMID:25811541
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Rab8a
RAB8A, member RAS oncogene family
multiple interactions increases uptake
ISO
[RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime RAB8A protein results in increased uptake of Cefixime
CTD
PMID:19074526
NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678
G
Slc15a1
solute carrier family 15 member 1
multiple interactions increases uptake
ISO
[RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime SLC15A1 protein results in increased uptake of Cefixime
CTD
PMID:19074526
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Cefmetazole
CTD
PMID:17939016
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cefonicid binds to and results in decreased activity of SLC25A20 protein; Cefonicid inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
Cefoperazone inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates]
CTD
PMID:12065749
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
cefoselis inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of cefoselis cefoselis inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Cefotaxime results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Il10
interleukin 10
multiple interactions
ISO
Cefotaxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Cefotaxime results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
RT1-CE5
RT1 class I, locus CE5
affects expression
ISO
Cefotaxime affects the expression of HLA-F mRNA
CTD
PMID:25811541
NCBI chr20:3,403,418...3,479,476
G
Tp53
tumor protein p53
increases expression
ISO
Cefotaxime results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Cefotetan results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
Cefotiam inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Cefotiam Cefotiam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Ifng
interferon gamma
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA]
CTD
PMID:37269894
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]
CTD
PMID:37269894
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL10 mRNA]
CTD
PMID:37269894
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL1B mRNA]
CTD
PMID:37269894
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA]
CTD
PMID:37269894
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA]
CTD
PMID:37269894
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of RELA mRNA]
CTD
PMID:37269894
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
RT1-CE16
RT1 class I, locus CE16
affects expression
ISO
Cefoxitin affects the expression of HLA-A mRNA
CTD
PMID:25811541
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
RT1-Ha
RT1 class II, locus Ha
affects expression
ISO
Cefoxitin affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA]
CTD
PMID:37269894
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]
CTD
PMID:37269894
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]
CTD
PMID:37269894
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Traf6
TNF receptor associated factor 6
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TRAF6 mRNA]
CTD
PMID:37269894
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Prl
prolactin
increases expression
ISO
Cefpodoxime results in increased expression of PRL protein
CTD
PMID:20083845
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Defb5
defensin beta 5
multiple interactions
ISO
Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of and results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased secretion of DEFB4A protein]
CTD
PMID:27397760 PMID:28720485
NCBI chr16:70,612,985...70,615,389
Ensembl chr16:70,613,146...70,615,467
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]]
CTD
PMID:27397760
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Tlr2
toll-like receptor 2
multiple interactions
ISO
Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR2 protein]
CTD
PMID:27397760
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR4 protein]
CTD
PMID:28720485
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in increased secretion of TNF protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of TNF protein]
CTD
PMID:28720485
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Ceftazidime
CTD
PMID:17939016
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Ceftazidime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Hsf1
heat shock transcription factor 1
decreases activity
ISO
Ceftazidime results in decreased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Il10
interleukin 10
multiple interactions
ISO
Ceftazidime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Slc15a1
solute carrier family 15 member 1
multiple interactions
ISO
[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of ceftibuten
CTD
PMID:14567632
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
G
Slc22a6
solute carrier family 22 member 6
increases uptake multiple interactions
ISO
SLC22A6 protein results in increased uptake of ceftibuten ceftibuten inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of ceftibuten ceftibuten inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Ceftizoxime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Slc22a6
solute carrier family 22 member 6
multiple interactions increases uptake
ISO
Ceftizoxime inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of Ceftizoxime
CTD
PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Ceftizoxime Ceftizoxime inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Ace2
angiotensin converting enzyme 2
decreases expression
EXP
Ceftriaxone results in decreased expression of ACE2 mRNA
CTD
PMID:29745864
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Actb
actin, beta
increases expression
EXP
Ceftriaxone results in increased expression of ACTB mRNA
CTD
PMID:29745864
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Bace1
beta-secretase 1
decreases expression
EXP
Ceftriaxone results in decreased expression of BACE1 mRNA
CTD
PMID:29745864
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Cat
catalase
decreases expression multiple interactions
ISO EXP
Ceftriaxone results in decreased expression of CAT protein Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]
CTD
PMID:19442074 PMID:25053526
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Ceftriaxone results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Ece1
endothelin converting enzyme 1
increases expression
EXP
Ceftriaxone results in increased expression of ECE1 mRNA
CTD
PMID:29745864
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
G
Epo
erythropoietin
increases expression
EXP
Ceftriaxone results in increased expression of EPO mRNA
CTD
PMID:29745864
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ide
insulin degrading enzyme
increases expression
EXP
Ceftriaxone results in increased expression of IDE mRNA
CTD
PMID:29745864
NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]]
CTD
PMID:25053526
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Mme
membrane metallo-endopeptidase
increases expression
EXP
Ceftriaxone results in increased expression of MME mRNA
CTD
PMID:29745864
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
G
Slc1a2
solute carrier family 1 member 2
multiple interactions increases expression
EXP
Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [JZL195 results in decreased expression of and affects the folding of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein] Ceftriaxone results in increased expression of SLC1A2 protein
CTD
PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 PMID:29432698
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc7a11
solute carrier family 7 member 11
multiple interactions
EXP
Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein]
CTD
PMID:19717140
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]]
CTD
PMID:25053526
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Cat
catalase
decreases activity
EXP
Cefuroxime results in decreased activity of CAT protein
CTD
PMID:30797828
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Il10
interleukin 10
multiple interactions
ISO
Cefuroxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases activity
ISO
Cefuroxime results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases activity
ISO
Cefuroxime results in decreased activity of NR1I3 protein
CTD
PMID:30203046
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Ppara
peroxisome proliferator activated receptor alpha
decreases activity
ISO
Cefuroxime results in decreased activity of PPARA protein
CTD
PMID:30203046
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
RT1-A2
RT1 class Ia, locus A2
affects expression
ISO
Cefuroxime affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr20:4,870,939...4,910,183
G
RT1-Bb
RT1 class II, locus Bb
affects expression
ISO
Cefuroxime affects the expression of HLA-DQB1 mRNA
CTD
PMID:25811541
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Ha
RT1 class II, locus Ha
affects expression
ISO
Cephalexin affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
Slc15a1
solute carrier family 15 member 1
increases transport
EXP
SLC15A1 protein results in increased transport of Cephalexin
CTD
PMID:19881305
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of cephalosporin C
CTD
PMID:17939016
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Slc15a1
solute carrier family 15 member 1
multiple interactions
ISO
[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of Cephradine
CTD
PMID:14567632
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO EXP
Cloxacillin results in decreased activity of ABCB11 protein
CTD
PMID:15618715
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Casp3
caspase 3
increases activity multiple interactions
ISO
Cloxacillin results in increased activity of CASP3 protein [Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [Cloxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
Dicloxacillin results in decreased activity of ABCB11 protein
CTD
PMID:20829430
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Ager
advanced glycosylation end product-specific receptor
multiple interactions increases expression
ISO
AGER protein affects the reaction [Dicloxacillin results in increased expression of GPT protein] Dicloxacillin results in increased expression of AGER mRNA
CTD
PMID:24747151
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions increases expression
ISO
[Progesterone co-treated with Dicloxacillin] results in increased expression of CXCL2 mRNA Dicloxacillin results in increased expression of CXCL2 mRNA
CTD
PMID:22157104 PMID:24747151
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression multiple interactions
ISO
Dicloxacillin results in increased expression of CXCL1 mRNA Progesterone promotes the reaction [Dicloxacillin results in increased expression of CXCL1 mRNA]
CTD
PMID:22157104
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression
ISO
Dicloxacillin results in increased expression of and results in increased activity of CYP3A4 protein Dicloxacillin results in increased expression of CYP3A4 mRNA
CTD
PMID:18505790
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases expression
ISO
AGER protein affects the reaction [Dicloxacillin results in increased expression of GPT protein]; eritoran inhibits the reaction [Dicloxacillin results in increased expression of GPT protein]
CTD
PMID:24747151
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Hmgb1
high mobility group box 1
increases expression
ISO
Dicloxacillin results in increased expression of HMGB1 protein
CTD
PMID:24747151
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
Dicloxacillin results in increased expression of ICAM1 protein
CTD
PMID:14729754
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il1b
interleukin 1 beta
increases expression
ISO
Dicloxacillin results in increased expression of IL1B mRNA
CTD
PMID:24747151
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
increases response to substance increases expression
ISO
IL4 results in increased susceptibility to Dicloxacillin Dicloxacillin results in increased expression of IL4 protein
CTD
PMID:21094227
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Nlrp3
NLR family, pyrin domain containing 3
increases expression
ISO
Dicloxacillin results in increased expression of NLRP3 mRNA
CTD
PMID:24747151
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Dicloxacillin results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
S100a8
S100 calcium binding protein A8
increases expression
ISO
Dicloxacillin results in increased expression of S100A8 mRNA
CTD
PMID:24747151 PMID:28138970
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
ISO
Dicloxacillin results in increased expression of S100A9 mRNA
CTD
PMID:24747151
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
ISO
Floxacillin results in decreased activity of ABCB11 protein Floxacillin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Floxacillin results in increased expression of AKR1B10 mRNA
CTD
PMID:28444390
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Alb
albumin
affects binding
ISO
Floxacillin binds to ALB protein
CTD
PMID:36782357
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Casp3
caspase 3
increases activity multiple interactions
ISO
Floxacillin results in increased activity of CASP3 protein [Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [Floxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO
Floxacillin results in increased expression of CCL2 mRNA
CTD
PMID:24652713
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cd69
Cd69 molecule
multiple interactions
ISO
[Floxacillin co-treated with CpG ODN 1826] results in decreased expression of CD69 protein
CTD
PMID:30993380
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
G
Ces1d
carboxylesterase 1D
affects binding
ISO
Floxacillin binds to CES1 protein
CTD
PMID:36782357
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cps1
carbamoyl-phosphate synthase 1
affects binding
ISO
Floxacillin binds to CPS1 protein
CTD
PMID:36782357
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Crp
C-reactive protein
multiple interactions
ISO
[Floxacillin co-treated with Gentamicins co-treated with Rifampin] results in increased expression of CRP protein
CTD
PMID:16943303
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
Floxacillin results in increased expression of CXCL2 mRNA
CTD
PMID:24652713
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
Floxacillin results in increased expression of CXCL1 mRNA
CTD
PMID:24652713
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases metabolic processing
ISO
CYP3A4 results in increased metabolism of Floxacillin
CTD
PMID:11409940
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Faslg
Fas ligand
multiple interactions
ISO
[Floxacillin co-treated with CpG ODN 1826] results in decreased expression of FASL protein; FASL protein affects the reaction [[Floxacillin co-treated with CpG ODN 1826] results in increased expression of GPT protein]
CTD
PMID:30993380
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Glud1
glutamate dehydrogenase 1
affects binding
ISO
Floxacillin binds to GLUD1 protein
CTD
PMID:36782357
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases expression
ISO
[Floxacillin co-treated with alpha-galactosylceramide] results in increased expression of GPT protein; [Floxacillin co-treated with CpG ODN 1826] results in increased expression of GPT protein; FASL protein affects the reaction [[Floxacillin co-treated with CpG ODN 1826] results in increased expression of GPT protein]; IL17A protein promotes the reaction [Floxacillin results in increased expression of GPT protein]
CTD
PMID:24652713 PMID:30993380
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Hba-a3
hemoglobin alpha, adult chain 3
affects binding
ISO
Floxacillin binds to HBA2 protein
CTD
PMID:36782357
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
G
Hbb
hemoglobin subunit beta
affects binding
ISO
Floxacillin binds to HBB protein
CTD
PMID:36782357
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Hmgb1
high mobility group box 1
increases secretion increases expression
ISO
Floxacillin results in increased secretion of HMGB1 protein Floxacillin results in increased expression of HMGB1 protein
CTD
PMID:24652713 PMID:28444390
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Il17a
interleukin 17A
multiple interactions
ISO
[IL17A protein co-treated with Floxacillin] results in increased expression of MPO protein; IL17A protein promotes the reaction [Floxacillin results in increased expression of GPT protein]
CTD
PMID:24652713
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1a
interleukin 1 alpha
increases secretion
ISO
Floxacillin results in increased secretion of IL1A protein
CTD
PMID:28444390
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases secretion multiple interactions increases expression
ISO
Floxacillin results in increased secretion of IL1B protein [Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein] Floxacillin results in increased expression of IL1B mRNA
CTD
PMID:24652713 PMID:28444390 PMID:30876886
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il5
interleukin 5
increases expression
ISO
Floxacillin results in increased expression of IL5 mRNA
CTD
PMID:24652713
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
increases secretion multiple interactions increases expression
ISO
Floxacillin results in increased secretion of IL6 protein [Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein] Floxacillin results in increased expression of IL6 mRNA
CTD
PMID:24652713 PMID:28444390 PMID:30876886
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mpo
myeloperoxidase
multiple interactions
ISO
[IL17A protein co-treated with Floxacillin] results in increased expression of MPO protein
CTD
PMID:24652713
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Rorc
RAR-related orphan receptor C
increases expression
ISO
Floxacillin results in increased expression of RORC mRNA
CTD
PMID:24652713
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
S100a8
S100 calcium binding protein A8
increases expression
ISO
Floxacillin results in increased expression of S100A8 mRNA
CTD
PMID:24652713
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
ISO
Floxacillin results in increased expression of S100A9 mRNA
CTD
PMID:24652713
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Floxacillin results in increased expression of SRXN1 mRNA
CTD
PMID:28444390
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Tbx21
T-box transcription factor 21
decreases expression
ISO
Floxacillin results in decreased expression of TBX21 mRNA
CTD
PMID:24652713
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
G
Tnf
tumor necrosis factor
increases secretion multiple interactions increases expression
ISO
Floxacillin results in increased secretion of TNF protein [Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein] Floxacillin results in increased expression of TNF mRNA
CTD
PMID:24652713 PMID:28444390 PMID:30876886
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tsen2
tRNA splicing endonuclease subunit 2
affects binding
ISO
Floxacillin binds to TSEN2 protein
CTD
PMID:36782357
NCBI chr 4:148,602,805...148,638,219
Ensembl chr 4:148,602,863...148,638,215
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Floxacillin results in increased expression of TXNRD1 mRNA
CTD
PMID:28444390
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ugp2
UDP-glucose pyrophosphorylase 2
affects binding
ISO
Floxacillin binds to UGP2 protein
CTD
PMID:36782357
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
affects binding
ISO
Floxacillin binds to YWHAB protein
CTD
PMID:36782357
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCB1A mRNA
CTD
PMID:24657338
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] affects the expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCC3 mRNA
CTD
PMID:24657338
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcg5
ATP binding cassette subfamily G member 5
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] affects the expression of ABCG5 mRNA
CTD
PMID:24657338
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] affects the expression of ABCG8 mRNA
CTD
PMID:24657338
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Baat
bile acid CoA:amino acid N-acyltransferase
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of BAAT mRNA
CTD
PMID:24657338
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of CYP7A1 mRNA
CTD
PMID:24657338
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of NR0B2 mRNA
CTD
PMID:24657338
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Imipenem results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc27a5
solute carrier family 27 member 5
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLC27A5 mRNA
CTD
PMID:24657338
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
G
Slc51a
solute carrier family 51 member A
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of SLC51A mRNA
CTD
PMID:24657338
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of SLCO1A4 mRNA
CTD
PMID:24657338
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLCO2B1 mRNA
CTD
PMID:24657338
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
RT1-DOb
RT1 class II, locus DOb
affects expression
ISO
meropenem affects the expression of HLA-DOB mRNA
CTD
PMID:25811541
NCBI chr20:4,619,418...4,625,627
Ensembl chr20:4,619,816...4,625,667
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
affects expression
ISO
Meropenem affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Casp3
caspase 3
increases activity multiple interactions
ISO
Nafcillin results in increased activity of CASP3 protein [Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [Nafcillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Nafcillin results in increased expression of CYP3A4 mRNA; Nafcillin results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Nafcillin results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ces1d
carboxylesterase 1D
increases expression
ISO
Penicillin V results in increased expression of CES1 mRNA
CTD
PMID:22609641
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Penicillin V results in increased expression of CYP3A4 mRNA; Penicillin V results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Penicillin V results in increased expression of GCLM mRNA
CTD
PMID:22609641
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Mir185
microRNA 185
decreases expression
EXP
Penicillin V results in decreased expression of MIR185 mRNA
CTD
PMID:22112502
NCBI chr11:82,664,716...82,664,795
Ensembl chr11:82,664,716...82,664,795
G
Mir296
microRNA 296
decreases expression
EXP
Penicillin V results in decreased expression of MIR296 mRNA
CTD
PMID:22112502
NCBI chr 3:163,051,838...163,051,915
Ensembl chr 3:163,051,838...163,051,915
G
Mir330
microRNA 330
decreases expression
EXP
Penicillin V results in decreased expression of MIR330 mRNA
CTD
PMID:22112502
NCBI chr 1:78,833,178...78,833,274
Ensembl chr 1:78,833,178...78,833,274
G
Mir34c
microRNA 34c
decreases expression
EXP
Penicillin V results in decreased expression of MIR34C mRNA
CTD
PMID:22112502
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
G
Mir433
microRNA 433
decreases expression
EXP
Penicillin V results in decreased expression of MIR433 mRNA
CTD
PMID:22112502
NCBI chr 6:128,545,119...128,545,211
Ensembl chr 6:128,545,112...128,545,217
G
Mir484
microRNA 484
decreases expression
EXP
Penicillin V results in decreased expression of MIR484 mRNA
CTD
PMID:22112502
NCBI chr10:887,684...887,760
Ensembl chr10:887,684...887,760
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Penicillin V results in increased expression of NQO1 mRNA
CTD
PMID:22609641
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Pir
pirin
increases expression
ISO
Penicillin V results in increased expression of PIR mRNA
CTD
PMID:22609641
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Trim16
tripartite motif-containing 16
increases expression
ISO
Penicillin V results in increased expression of TRIM16 mRNA
CTD
PMID:22609641
NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Piperacillin
CTD
PMID:17939016
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases activity multiple interactions
ISO
Piperacillin results in decreased activity of CYP2C8 protein Piperacillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine]
CTD
PMID:26763401
G
Ifng
interferon gamma
increases secretion
ISO
Piperacillin results in increased secretion of IFNG protein
CTD
PMID:29644860
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of IL1B mRNA]
CTD
PMID:16369182
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il22
interleukin 22
increases secretion
ISO
Piperacillin results in increased secretion of IL22 protein
CTD
PMID:29644860
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Mir155
microRNA 155
increases expression
ISO
Piperacillin results in increased expression of MIR155 mRNA
CTD
PMID:29644860
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir18a
microRNA 18a
increases expression
ISO
Piperacillin results in increased expression of MIR18A mRNA
CTD
PMID:29644860
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
G
Mir21
microRNA 21
increases expression
ISO
Piperacillin results in increased expression of MIR21 mRNA
CTD
PMID:29644860
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mr1
major histocompatibility complex, class I-related
affects expression
ISO
Piperacillin affects the expression of MR1 mRNA
CTD
PMID:25811541
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
RT1-DMb
RT1 class II, locus DMb
affects expression
ISO
Piperacillin affects the expression of HLA-DMB mRNA
CTD
PMID:25811541
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Piperacillin binds to and results in decreased activity of SLC25A20 protein; Piperacillin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of TNF mRNA]
CTD
PMID:16369182
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abcc4
ATP binding cassette subfamily C member 4
increases transport
ISO
ABCC4 protein results in increased transport of Sulbactam
CTD
PMID:17939016
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of IL1B mRNA]
CTD
PMID:16369182
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of TNF mRNA]
CTD
PMID:16369182
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all